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1 Introduction 
1.1 Biology of the Liver 
The liver is an exceptional organ in terms of its metabolic, synthesizing and detoxifying 
functions. It has the unique potential to regenerate after tissue loss and, for instance, 
plays an important role in the regulation of blood glucose or blood lipids. All these and 
many other functions represent the organ’s ability to execute proper reaction towards 
the body’s demands and keeping it in homeostasis. The central function of the liver for 
homeostasis and inflammatory responses is also underscored by its sole anatomical 
location, allowing continuous blood supply from the arterial system (hepatic arteries) 
and from the gastrointestinal tract via the portal vein (Figure 1). The liver, not only 
comprises classical parenchymal cells (hepatocytes) or non-parenchymal ‘structural’ 
cells such as sinusoidal endothelial cells, but also contains a fairly large number of 
seemingly liver-resident immune cells, mainly macrophages (Kupffer cells), natural killer 
(NK) and natural killer T (NKT) cells. In addition, circulating blood cells from the innate 
or adaptive immune system are pressed through a 
network of sinusoids allowing contact to the 
intrahepatic cell populations (Figure 2) (1,2).  
 
Chemotactic cytokines, ´Chemokines´ are small 
proteins that direct the migration of immune cells via 
chemokine-chemokine receptor interactions. It 
becomes more and more evident that the chemokine-
directed infiltration of immune cells is a crucial 
pathogenic factor in acute and chronic liver diseases. 
 
Figure 1: Liver microanatomy Microanatomy of the liver shows its vasculature and the location of 
different cell types. Constant blood flow through these venules makes liver, an important organ in immune 
regulation and is prone to blood derived toxic or pathogenic challenge which finally ends up in 
immunopathogenesis of liver. Figure modified, originally released on www.niaaa.nih.gov. 
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1.2 Intrahepatic immune cells
Besides its various metabolic functions, the liver is also a central “immunological” organ. 
Blood coming from the gastrointestinal tract is enriched of potential antigens, and 
immune cells in the liver have the potential to initiate both: a) innate and adaptive 
immune responses in the case of infections, e.g. in response to lipopolysaccharide 
(LPS) or bacterial super antigens, or b) immunological tolerance in the vast majority of 
harmless antigens during homeostasis (1,2).  
            
              
   
 
ure 2: Intrahepatic immune cell populations. The healthy liver comprises about 60-80% Fig
hepatocytes; the other intrahepatic cell populations include biliary cells, liver sinusoidal endothelial cells 
(LSECs) lining the liver sinusoids, macrophages / Kupffer cells (KC), NKT cells and hepatic stellate cells 
(HSC) in the Dissé space between hepatocytes and LSECs. In addition, many immune cells are found in 
the liver, mainly entering from the circulation via hepatic arteries and portal vein branches, including 
neutrophils (PMN), monocytes, dendritic cells (DCs) and lymphocytes (T, B, NK, NKT cells). 
 
 
 
 
hepatic
artery
portal
vein
monocytes
T, B, NK
DCs
bile
duct
central
vein KC
HSC
LSECs
sinusoid
NKT
PMN
1 Introduction
3
1.2.1 Innate immune effector cells in the liver
 cells), natural killer (NK) and 
ecent data challenged this concept, as mouse models using bone marrow 
Kupffer cells (resident or monocyte-derived) have the capacity to phagocyte and to 
  
The liver is selectively enriched in macrophages (Kupffer
natural killer T (NKT) cells. Although it has been long known that Kupffer cells principally 
originate from bone-marrow-derived monocytes (3), Kupffer cells have long been 
considered a rather sessile, tissue-resident and (fairly) radio-resistant population (3,4).  
 
R
transplantation and experimental liver transplantation revealed that more than half of the 
Kupffer cells in a steady state liver originate directly from bone-marrow precursors, 
indicating a high turnover rate of macrophages in liver homeostasis (5,6). In the case of 
inflammation, blood-derived infiltrating monocytes may become even more dominant for 
macrophage actions, as suggested by animal models of chronic liver injury and 
fibrogenesis (6,7). Monocytes consist of at least two major subsets with different 
migratory and functional properties (8,9,10); their specific roles in liver homeostasis and 
inflammation as macrophage-precursors are the subject of intensive ongoing research 
and main focus of this PhD thesis. 
 
release a broad panel of cytokines, which critically determine the subsequent reactions 
of other immune cells and hepatocytes as well as the degree of organ damage (10). 
Kupffer cells can release a variety of pro-inflammatory cytokines such as tumor-necrosis 
factor alpha (TNF-alpha), interleukin-6 (IL-6), IL-1-beta (IL-1) or leukotrienes (11), but on 
the other hand, e.g. in the context of low “physiological” levels of LPS, also anti-
inflammatory cytokines like IL-10 (12). In acute or chronic liver diseases, Kupffer cells 
and infiltrating monocyte-derived macrophages are well known to promote inflammatory 
cascades by releasing these pro-inflammatory mediators with consequences like T cell 
attraction, induction of hepatocyte apoptosis or activation of fibrogenic hepatic stellate 
cells (10,13). 
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How ta indicated that macrophages are also required to 
Natural killer (NK) cells represent a subpopulation of lymphocytes with potent 
cytol
KT cells are a subpopulation of ‘unconventional T cells’, as they express surface 
mark
ever, recent experimental da
restrict the inflammatory response and to degrade extracellular matrix proteins for the 
regression of liver fibrosis (4,14). 
 
ytic activity against virus-infected or tumor cells. Hepatic NK cells functions are 
regulated by Kupffer-cell derived cytokines, e.g. IL-12 and IL-18, as well as NKT cell-
driven IL-4; NK cells produce large amounts of interferon gamma (IFN-) upon 
activation during viral infections (15). Hepatic NK cells modulate T cell responses in the 
liver, promote intracellular changes in endothelial cells and hepatocytes (mainly via IFN-
) and can even directly promote hepatocyte death or cell lysis (16). In chronic 
inflammatory conditions, e.g. chronic hepatitis B virus infection, liver injury is closely 
linked to NK-mediated IL-8 and IFN-alpha (IFN-) synthesis as well as accumulation 
and activation of NK cells in the liver expressing the apoptosis-inducing TNF-related 
apoptosis inducing ligand (TRAIL) (17). 
 
N
ers of T and NK cells, which are found at unusually high frequencies in the liver. 
From studies of experimental liver injury in mice after administration of the plant-derived 
lectin Concanavalin A (Con A), NKT cells have long been identified as critical factors 
promoting acute liver damage by release of IL-4, IFN- and direct induction of Fas-
mediated hepatocyte apoptosis (18). However, their physiological function has remained 
somewhat obscure. Recent studies revealed an important role of NKT cells in the early 
response against microbial infections, as exogenous and endogenous glycolipid 
antigens from bacteria were found to activate NKT cells (19,20,21). Furthermore, NKT cells 
are involved in antiviral defense mechanisms, e.g. during chronic hepatitis B virus 
infection as suggested by studies in transgenic mice (22).  
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1.2.2 Antigen presenting cells and adaptive T cell responses in the
on of adaptive immune responses, antigens need to be processed and 
e recently, hepatic stellate cells, known for vitamin A storage and collagen 
synth
.3 Chemokines 
otactic cytokines professionalized in recruiting leukocytes to sites 
         liver  
For the initiati
professionally presented to T cells, either in the liver itself or in the draining lymph node 
(1). Several hepatic cell populations have antigen-presenting properties. In non-
inflammatory conditions, antigen-presentation by liver sinusoidal endothelial cells 
appears to be a crucial mechanism for the maintenance of immunological tolerance (22). 
Furthermore, Kupffer cells and also bone-marrow derived dendritic cells, mostly likely of 
monocytic origin, can efficiently prime T cells (10,11). The nature of the T cell response, 
e.g. T-cell cytotoxicity in the case of a chronic viral infection or T-cell tolerance in the 
case of harmless gut-derived antigens or auto antigens, seems to depend on the 
antigen-presenting cells, the cytokine milieu and the site of primary T cell activation 
(23,24,26).  
Mor
esis in liver fibrosis, have been identified as cells with antigen-presenting capacity 
that can activate T cell responses, e.g. after bacterial challenge (25,26,27,28).  
1
Chemokines are chem
of injury and inflammation (29). They represent a family of low molecular weight proteins 
(approximately 8-10 kilodaltons in size) that can be separated into four distinct structural 
groups by their relative positioning of cysteines (C) at the amino terminus (Table 1.0). 
Many of the chemokine receptors bind more than one chemokine, and some 
chemokines bind more than one receptor. This redundancy in the chemokine-
chemokine receptor network considerably impedes the distinct designation of the single 
chemokine’s function in a pathological setting such as acute or chronic liver disease 
(Table 1.0).  
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Classically, chemokines are defined as chemotactic cytokines that drive the 
migra
Following liver injury, the resident hepatic cell types are capable of secreting various 
.3.1 Chemokines in acute liver disease 
hepatitis with jaundice, coagulopathy 
tion of immune cells, e.g. from the vasculature into the injured tissue, via a 
gradient of increasing chemokine concentrations towards the source of chemokine 
production (29,30,31). 
 
chemokines (Table 2.0). The exact dissection of chemokine-chemokine receptor 
interactions for the attraction of certain immune cell subpopulations during initiation, 
progression or regression of acute or chronic liver diseases may possibly represent 
novel and presumably highly specific therapeutic targets in the future. This prompted 
intensive research using adequate animal models of liver injury and genetically modified 
mice deficient for these targets. 
 
1
Acute liver failure (ALF) is defined as a fulminant 
and hepatic encephalopathy in patients without recognized underlying liver disease. 
Recent studies suggest approximately 1,600 acute liver failure (AFL) cases per year in 
the United States (US) and approximately 200 cases in Germany. Even in highly 
developed countries such as the US, the mortality of this clinical condition still reaches 
40%, with about 45% surviving with supportive intensive care and 15% requiring 
emergency liver transplantation (32). The most common etiology for ALF in the Western 
world is toxicity of the analgetic acetaminophen (”paracetamol”), in Asia acute infection 
with the hepatitis B or other hepatotropic (hepatitis A, E) viruses (32,33,34). Histologically, 
there is diffuse hepatic infiltration of inflammatory cells accompanied by massive 
multilobular necrosis (30). 
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Table 1.0: Overview about the chemokines and their corresponding
Family Ligand Alternative name Corresponding receptor 
      receptors 
 
ly 
 
X
CL2 
 
CM-1 
C fami
 
CL1 
X
 
lymphotactin,SCM-1
S
 
XCR1 
 
 
C-C family 
CL2 
 
 
CP1 
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IP-1 
CP-5 
eukotactin 
EC 
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-1 
2,Eotaxin-2 
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CR3 
CR3 
 
CR10 
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C
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CCL10
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CCL12 
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CCL14 
CCL15 
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CCL21 
CCL22 
CCL23 
CCL24 
CCL25 
CCL26 
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MIP-1
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MCP-3 
MCP-2 
MRP-2,M
 
Eotaxin 
M
MCP-4 
HCC-1 
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CCR2 
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CCR1,C
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unknown 
CCR7 
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CCR4 
CCR1 
CCR3 
CCR9 
CCR3 
CCR10
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CXC family CXCL1 
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Gro-, KC 
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8 
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CXCR2 
XCR2 
XCR2 
XCR2 
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G
Gro 
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unknown
unknown
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CX3C family 
 
ractalkine 
 
CX3CL1 
 
F
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Several experimental acute liver injury models have been developed in mice to 
reveal underlying pathogenic immune mechanisms of ALF. The model of Concanavalin 
A (C
e in the model 
of Con A hepatitis, and this is largely modulated by chemokines. CCL3/MIP-1alpha acts 
pro-i
the infiltration of monocytes is an important 
pathogenic factor during acute liver injury, too. CCR5-KO mice were described to 
displ
on A)-induced hepatitis has been widely used to study mechanisms of immune-
mediated liver injury. Con A is a bean lectin, which, when injected intravenously to mice, 
induces activation of T cells in the liver, and NKT cells have been found most important 
as they together with Kupffer cells secrete large amounts of hepatotoxic cytokines, most 
notably TNF- and IFN- (19). Other models include the induction of liver damage by 
toxins such as lipopolysaccharide (LPS), acetaminophen or carbon tetrachloride and 
surgical models like partial hepatectomy and ischemia/reperfusion injury. 
 
The infiltration and activation of NK, NKT and CD4+ T cells is decisiv
nflammatory by recruiting CCR1-expressing CD4+ T cells to the liver (35). Also, 
CCL5/RANTES acts pro-inflammatory in this model as it favors recruitment of NK cells 
via CCR1 (16). The latter function was unraveled in knockout (KO) mice for the receptor 
CCR5 that react with elevated expression of the chemokine CCL5 to liver injury. 
Besides an altered NK cell infiltration, CCR5-KO mice show a prolonged activation of 
CD1d+ NKT cells (36,37), underlining that chemokines do not only influence immune cell 
attraction, but also immune cell functions. 
 
As in chronic liver disease models, 
ay increased mononuclear infiltrates in the Con A model, most likely due to an 
increased attraction of pro-inflammatory monocytes via CCR1 (35). Data from 
acetaminophen-induced acute liver injury, however, point towards an important 
opposing role of CCL2 (MCP-1) for the recruitment of CCR2+ monocytes, acting anti-
inflammatory and limiting the acute liver damage (38). Consequently, CCR2-KO mice 
were more susceptible to acetaminophen-induced liver damage (39). 
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A specific feature of acute drug-induced hepatitis in humans is the hepatic infiltration of 
eosinophils. In liver biopsy samples of these patients, CCL11 (eotaxin) is specifically 
upregulated, most likely promoting eosinophil infiltration (40).  
 
Increased expression of CCL11 (Eotaxin) by hepatocytes and sinusoidal 
endothelial cells accompanied by increased serum eotaxin levels is also observed in 
Con A-induced Hepatitis, resulting in the recruitment of eosinophils and neutrophils into 
the injured liver; eotaxin blockade attenuated Con A-induced Hepatitis and leukocyte 
infiltration (40,41). 
 
1.3.2 Chemokines in chronic liver disease 
Although chronic liver disease has many etiologies, including chronic infections with the 
hepatitis B or C virus, alcohol abuse, metabolic syndrome, and autoimmune disorders, 
the cellular and pathological mechanisms leading to liver fibrosis and – as an end-stage 
– cirrhosis are believed to be relatively common and uniform. Liver fibrosis is 
characterized by an accumulation of extracellular matrix proteins; activated hepatic 
stellate cells (HSC), portal fibroblasts and myofibroblasts have been identified as major 
collagen-producing cells in the injured liver (42). These cells are activated by fibrogenic 
cytokines such as TGF-1. The initiation of fibrogenesis crucially depends on an 
inflammatory phase in which liver resident macrophages, Kupffer cells, are activated 
and release TGF- as well as a variety of proinflammatory cytokines, and immune cells 
are recruited (42).  
 
Recruited inflammatory cells (T lymphocytes, monocytes, or neutrophils) can activate 
HSCs to secrete collagen. Activated HSC in turn secrete inflammatory chemokines, 
express cell adhesion molecules, and modulate lymphocyte activation, perpetuating a 
vicious circle in which inflammatory and fibrogenic cells stimulate each other (43,44,45). 
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Findings from patients with chronic liver disease, e.g. chronic hepatitis C virus infection, 
and from animal models using genetically modified mice, e.g. in models of liver 
fibrogenesis induced by carbon tetrachloride (CCl4) or surgical biliary duct ligation, have 
identified that chemokines and chemokine receptors are involved in all stages of chronic 
liver disease, namely during initiation of liver injury, the inflammatory phase, the 
fibrogenic phase and also during disease regression (44,45,46,47).Careful analyses of 
samples (liver / blood) from patients with chronic liver disease and liver cirrhosis have 
revealed that many chemokines are found to be elevated in these conditions (43,45,46) 
(Table 2). 
Table 2.0: Overview about the chemokines that can be expressed upon liver  
   injury by different cell-types within the liver 
Cell type  Chemokine
 
Hepatocytes 
 
MCP-1 (CCL2)38, MIP-1 (CCL3)74, RANTES (CCL5)16,74, MIP3 (CCL19)75,SLC 
(CCL21)75 ,Mig (CXCL9)64, IP-10 (CXCL10)64, CXCL1676,LEC (CCL16)15, IL-8 
(CXCL8)78, Eotaxin (CCL11)41
 
Stellate cells 
 
MCP-1(CCL2)52,60,MIP-1 (CCL3)60,MIP-1 (CCL4)60, CX3CL159, KC (CXCL1)60,MIP-2 
(CXCL2)60,IP-10 (CXCL10)60 and SLC (CCL21)70
 
Kupffer cells 
 
MCP1(CCL2)52,38,60,79,MIP-1 (CCL3)80 and MIP-3 (CCL20)56
 
Liver endothelial 
cells 
 
MCP-1(CCL2)52,IL-8 (CXCL8)81,76  CXCL1612, Mig (CXCL9)69,IP-10 
(CXCL10)69,CXCL16 65,CX3CL141,SLC (CCL21)83, Eotaxin (CCL11)41 and TECK 
(CCL25)73
 
For instance, CCL2 / MCP-1, the ligand for CCR2, is systemically elevated in patients 
with cirrhosis (49,50), and MCP-1 gene polymorphisms can be associated with hepatic 
MCP-1 expression and the severity of hepatitis-C-virus-(HCV) related liver disease (48). 
MCP-1 is present in the portal tracts of fibrotic livers and associated with mononuclear 
infiltrates (49,50). Intrahepatic expression of CCL5 (RANTES), a ligand for CCR1 and 
CCR5, is upregulated in patients with chronic liver disease (48), and CCR5 
polymorphisms are important for the disease progression in HCV-infected patients (49,50).  
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Also, hepatic expression of CCL20 / MIP-3, the ligand for CCR6, is upregulated 
in human liver cirrhosis; as CCR6+CD4+ T cells are also found at increased levels 
during liver fibrosis, MIP-3 / CCR6 might be involved in the amplification of local 
necroinflammatory responses in the liver by attracting T cell subtypes (56). Moreover, 
CCL11 / eotaxin is systemically elevated in patients with chronic liver disease and 
associated with disease progression and hepatic necroinflammation (52). 
 
The intrahepatic up-regulation of both, fractalkine (CX3CL1) and the fractalkine 
receptor (CX3CR1), in patients with various liver diseases suggested that this 
chemokine is as well involved in the pathogenesis of liver injury (53,54). 
 
However, our understanding on the interplay between resident hepatic cells, infiltrating 
immune cells and their fine-tuning via chemokines and chemokine receptors at these 
stages of disease progression is yet not complete. As stated above, activated HSC are 
a well recognized source of chemokines in the chronically injured liver (Table 2). The 
culture of primary human and murine HSC that are activated during the 
transdifferentiation process has revealed that activated HSC secrete many inflammatory 
chemokines, including CCL2, CCL3, CCL4, CCL5, CXCL1, CXCL2 and CXCL10 
(53,55,56,63). Experimental animal models of chronic liver injury and fibrosis using 
transgenic mice or selective blockade of chemokines may help to understand the 
distinct effects on the attraction of certain immune cell subpopulations. 
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1.4 Immune cell infiltration in liver diseases and experimental 
      liver Injury models 
1.4.1 NKT cell infiltration  
NKT cells highly express the chemokine receptor CXCR3. The interferon-inducible 
chemokine CXCL9 has been found to be the main ligand for NKT cell recruitment into 
the liver in acute inflammatory conditions (54). CXCL9 is expressed by hepatocytes in 
response to injury (53). Although it is very likely that the CXCL9-CXCR3 pathway also 
modulates NKT cell infiltration during chronic liver disease, this hypothesis needs to be 
confirmed in models of liver fibrosis. Recently it has been shown that CXCR3 receptor 
knockout mice developed severe experimental CCl4 induced liver fibrosis compared to 
their WT counterparts revealing the importance of NKT infiltration during liver injury (118). 
1.4.2 T cell infiltration 
The involvement of T cells in the pathogenesis of chronic liver diseases is well 
established, initially based on findings in patients with chronic hepatitis B or C virus 
infection in which insufficient virus-directed immune responses result in chronic 
inflammation, but not in efficient clearance of the virus (55,56). More recent studies 
revealed that additional endogenous factors, such as regulatory T cells (‘Tregs’) and 
immunosuppressive cytokines, exist in these conditions (57,58).  
          However, relatively little is undoubtedly known about the chemokines involved in 
T cell attraction during chronic liver disease. CD4+ T cells with a Th1-type pro-
inflammatory cytokine profile likely utilize CCR5 and CXCR3 for their 
migration/accumulation in portal regions (59,60). Observational studies from human 
samples indicate that CD8+ T cells express CCR7, a chemokine receptor well known for 
the migration of dendritic cells, and may be attracted by the CCR7-ligand CCL21 that is 
secreted by HSC (61).  
 
Tregs, on the other hand, may utilize CXCR3 and CCR10 for their recruitment into the 
inflamed liver, with CCR10 responding to CCL28 secreted by epithelium (65). 
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Appropriate animal models are currently being developed to address chemokine 
pathways for T cell recruitment in vivo. 
 
1.4.3 Monocyte/Macrophage infiltration
It has been recently demonstrated that the infiltration of (blood-derived) monocytes and 
macrophages is an important contributing factor for the progression of chronic liver 
diseases as it can promote the activation of fibrogenic stellate cells in vivo(15).  
 
The chemokine CCL2 (‘monocyte-chemoattractant protein-1’, MCP-1), the ligand for the 
chemokine receptor CCR2, is apparently involved in attracting monocytes into the 
injured liver (38,39), because blocking CCL2 inhibits the activation of hepatic stellate cells 
and liver fibrogenesis in rats (6). However, monocytes (human and murine) consist of at 
least two subsets with different migratory and functional properties (7). These subsets 
have a differential chemokine receptor pattern: murine Gr-1 / Ly6Chi monocytes express 
CCR2, CX3CR1, CCR1, whereas Gr-1 / Ly6Clow monocytes express CCR5 and higher 
levels of CX3CR1 and CCR6 (67,68,69). Their counterparts in humans are CD14++ and 
CD14+CD16+ monocytes, respectively. 
 
CD14+
CD16-
CD14low
CD16+
CD115+
Gr-1high CD115+
Gr-1low
CD11clow
CCR2 
CX3CR1 
CCR6 
Human
Mouse
Monocyte 
As the ligands for these receptors are also up-regulated during chronic liver disease, at 
least in patients, it remains to be clarified which monocyte subsets are recruited via 
these pathways during liver disease 
progression and also resolution.  
 
Figure 3: Monocyte subsets: Circulating monocytes 
consists of two principle subsets based on their 
chemokine receptor expression, recruitment and 
functional properties. Human monocyte subpopulations 
express CD14++ or CD14+CD16+, whereas their murine 
counterparts are Gr-1high or Gr-1low monocytes. 
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Besides effects on immune cell attraction, CX3CL1 may also have direct effects on HSC 
that were also found to express the fractalkine receptor CX3CR1 (71,72,73).   
1.5 Aims of this study 
Immune-mediated liver injury is a major cause of chronic liver damage and liver failure 
among patients. Even though there are many etiologies behind the initiation of the liver 
damage such as Hepatitis B, Hepatitis C virus infections, chronic alcoholism and non-
alcoholic steatohepatitis (NASH), all result in recruitment of inflammatory leukocytes 
(“chronic hepatitis”) and subsequently in liver fibrosis. Given the increasing body of 
evidence about the critical importance of macrophages for regulating liver inflammation 
and fibrogenesis as well as the recent identification of functionally diverse monocyte 
subsets, we proposed the following working hypothesis. 
 
Research hypothesis: 
Murine monocyte subsets (Gr-1high vs. Gr-1low) are differentially recruited during acute 
and chronic experimental liver injury, use distinct chemokine-chemokine receptor 
pathways such as the chemokine receptor CCR2 for their intrahepatic accumulation and 
fulfill critical functions in the initiation and progression of liver fibrosis.  
 
In order to prove or disprove the working hypothesis, the experimental procedures were 
designed to elucidate the following aims. 
 
1.5.1   Analysis of monocyte subset infiltration in acute and
           chronic liver injury 
Although it has been well known that CCl4 is a hepatotoxic agent and causes liver 
injury, there are no clear studies available characterizing the infiltrating leukocyte 
populations during liver injury caused by CCl4. Hence it has been established a 
gradient-based isolation protocol to characterize infiltrating leukocytes by multi-color 
FACS analysis, especially focussing on the recruitment of monocyte subsets during 
1 Introduction
15
acute and chronic liver injury of C57Bl/6 wild type mice. The findings were confirmed by 
conventional histology, biochemical analyses and immunohistochemistry. 
Having enriched leukocytes in hand a flow cytometric method of cell type 
quantification especially the monocytes using 6 color FACS Canto II flow cytometer has 
been established. The infiltrating monocytes were further characterised by their subsets 
using fluorescent-labelled antibodies using the state of art flow cytometric analysis. 
1.5.2    Role of the chemokine receptors CCR2 and CCR6 for 
            monocyte subset recruitment in acute and chronic livery  
There have been reports showing that monocyte subsets differentially express the 
chemokine receptors CCR2 and CCR6 (74, 75, 76). Recently it has been shown that the 
monocyte egress from the bone marrow into the blood stream is dependent on CCR2-
mediated signalling (77). Even though there are evidences, describing the involvement of 
chemokine receptors CCR2 and CCR6 during liver injury (76, 78, 79, 80, 82) it is currently 
unclear if the hepatic recruitment of monocyte subsets is regulated via CCR2 and/or 
CCR6.  In this study knock-out mice deficient for the chemokine receptor CCR2 or both 
CCR2 and CCR6 were employed in order to study the role of these receptors in 
monocyte recruitment during CCl4 mediated acute and chronic liver injury. The 
expression of the CCR2- and CCR6-specific ligands, CCL2 or CCL20, respectively, was 
monitored by real-time quantitative PCR and protein analysis. 
 
1.5.3    Functional role monocyte subset infiltration during liver 
            fibrogenesis and molecular mechanisms of these actions 
In order to prove the functional contribution of these monocyte subpopulations during 
chronic liver injury and fibrogenesis, Gr-1hi monocytes were isolated using the MACS 
separation method from the bone marrow of wild type animals and adoptively 
transferred to the wild type as well as chemokine receptor CCR2/CCR6-knockout 
animals during experimental liver injury. In addition to the in vivo experiments, an in vitro 
model to elucidate the role of these Gr-1hi monocytes was established by culturing them 
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together with an immortalized mouse hepatic stellate cell line GRX together with proper 
control cell types. This allowed dissecting the cellular interactions between monocytes 
and hepatic stellate cells and unraveling key molecular mechanisms of monocyte-
induced stellate cell activation. 
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 2.1 Materials 
 
2.1.1 Chemicals 
 
Name of the product Company 
Acetic Acid (glacial) Merck 
Acidic Fuchsine Chroma 
Aluminium Potassium Sulfate Dodecahydrate Merck 
Aminocaproic Acid Roth 
Ammonium Persulfate (APS) AppliChem 
Anilin Blue Chroma 
Carbon Tetrachloride (CCl4) Sigma 
Chloroform Mallinckrodt Baker 
Citric Acid Monohydrate Sigma 
Chloral Hydrate Merck 
Chloramine T Hydrate Sigma 
Diethyl Pyrocarbonate (DEPC) 97% Sigma 
Dithiothreitol (DTT) 1 M AppliChem 
4-Dimethylaminobenzaldehyde Sigma 
Deoxycholic Acid 97% Sigma 
Eosin Merck 
Ethanol (absolute) AppliChem 
Ethidium Bromide (EtBr) 1% Roth 
Ethylene Diamine Tetra-Acetic Acid (EDTA) AppliChem 
Fetal Calf Serum (FCS) PAA 
Ferric Chloride Merck 
Formaldehyde 37% Roth 
Haematoxilin Merck 
Hydrogen Peroxide 30% AppliChem 
Hydrochloric Acid 37% Roth 
cis-4-Hydroxy-D-Proline Sigma 
Isopropanol Merck 
Orange G Merck 
Paraformaldehyde (PFA) Roth 
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Perchloric Acid 70% Sigma 
Phenylmethanesulfonylfluoride (PMSF) 100mM AppliChem 
Sodium Azide AppliChem 
Sodium Acetate Trihydrate Sigma 
Sodium Chloride Sigma 
Sodium Dodecyl Sulfate (SDS) Sigma 
Sodium Hydroxide Pellets Merck 
Sodium Iodate Merck 
Sodium Orthovanadate 0.1 M AppliChem 
Tetramethylethylenediamine (TEMED) Bio-Rad  
Tris(hydroxymethyl)aminomethane (Tris) Fluka  
Tris Hydrochloride (Tris-HCl) Roth 
Trisodium Citrate Dihydrate 99% Roth 
Tungstophosphoric Hydrate Merck 
 
 
2.1.2 Instruments and Equipment  
  
7300 Real Time PCR System Applied Biosystems(Darmstadt,Germany) 
Amersham Hyperfilm MP GE Healthcare (Buckinghamshire, UK) 
AxioCam MRm Camera Zeiss (Göttingen, Germany) 
Axio Imager.Z1 Fluorescence Microscope Zeiss (Göttingen, Germany) 
BD FACSCanto II Flow Cytometer BD (Erlangen, Germany) 
Biophotometer Eppendorf (Wesseling-Berzdorf, 
Germany) 
Cell Strainer (70 μm) BD 
Concentrator Plus Speedvac Eppendorf 
DM1000 Bright Field Microscope Leica 
DS2MV Camera Nikon (Tokyo, Japan) 
Fastblot B43/B44 Blotting Chamber Biometra 
Filter Papers MN 615 ¼ Ø 150 mm Macherey-Nagel (Düren, Germany) 
Haematokrit Capillaries with Na-Heparin Hirschmann (Eberstadt, Germany) 
HM 550 Cryostat Microm (Walldorf, Germany) 
Microlance 3 20G Needle BD 
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Microlance 3 27G Needle BD 
Microscope Slides Super Frost Roth 
Millex GP Filter Unit (0.22 μm) Millipore 
Mini Protean Tetra Electrophoresis Cell Bio-Rad 
Modular Analytics Evo Serum Work Area Roche/Hitachi 
Omnican F 0.3x12 mm 1ml Syringe Braun (Melsungen, Germany) 
Plasticware Eppendorf and BD Falcon 
μQuant Microplate Spectrophotometer Bio-Tek (Winooski, USA) 
Scopix LR 5200 Film developing machine Agfa (Köln, Germany) 
Stericup (0.22 μm) Millipore (Billercia, USA) 
T3000 Thermocycler Biometra (Göttingen, Germany) 
Homogenizer Janke & Kunkel (Staufen, Germany) 
Whatman Chromatography Paper (3 mm) Whatman (Maldstone, England) 
Ultra Turrax (for RNA) IKA 
 
2.1.3 Analytical Chemicals, Reagents and Kits 
 
Acrylamide/Bis Solution 30% Bio-Rad 
Agarose Electrophoresis Grade Invitrogen (Carlsbad, USA) 
Aqua Delta Select Delta Select (Pfullingen, Germany) 
Bio-Rad Protein Assay Bio-Rad 
Bovine Serum Albumin (BSA) Sigma 
Brefeldin A AppliChem 
Concanavalin A (Con A) Sigma 
Cytofix/Cytoperm BD 
Dulbecco´s Modified Eagle Medium (DMEM) PAA 
Dulbecco´s Phosphate Buffered Saline (PBS) PAA 
ECL Western Blotting Detection Reagents GE Healthcare 
Hank´s Balanced Salt Solution (HBSS) PAA 
In Situ Cell Death Detection Kit Fluorescin Roche (Mannheim, Germany) 
In Situ Cell Death Detection Kit Red Roche (Mannheim, Germany) 
Ionomycin Calcium Salt Sigma 
Lymphocyte LSM 1077 PAA 
Nonfat Dried Milk Powder AppliChem 
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Nonidet P40 Substitute (NP40) AppliChem 
peqGOLD TriFast peqLab (Erlangen, Germany) 
Perm/Wash Buffer BD 
Pharmlyse 10x BD 
Phorbol-12-myristate-13-acetate (PMA) AppliChem 
Ponceau S Solution Sigma 
Precision Plus Protein Dual Colour Standards Bio-Rad 
Protease Inhibitor Cocktail Tablets Roche 
R1/R2 ALT Detection Reagents Roche 
REDTaq Ready Mix Sigma 
RNAse Zap Sigma 
Roswell Park Memorial Institute (RPMI) PAA 
Roti Load1 4x Roth 
Rotiphorese 10x SDS PAGE Roth 
Rotistock 10x TBST Roth 
Serum, Human Sigma 
Serum, Mouse Sigma 
Serum, Rabbit Sigma 
SYBR GreenqPCR Supermix Invitrogen 
Tissue-Tek O.C.T Compound Sakura (Heppenheim, Germany) 
Transcriptor First Strand cDNA Synthesis Kit Roche 
Tris-Acetate-EDTA Buffer (TAE) 50x AppliChem 
TritonX-100 AppliChem 
TUNEL Dilution Buffer Roche 
Tween 20 Sigma Ultra Sigma 
Vecta shield Mounting Medium with DAPI Vector (Burlingame, USA) 
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2.1.4 Primers for genotyping and RT-PCR 
 
All real time primers were designed with Clone Manager Version 6.0 considering 
exon-exon Junctions and designed at least one strand will bind at the exon-exon 
junction and were synthesized by MWG (Ebensburg, Germany). 
 
Table 2.1.1 Primer sequences 
 
Target Name  S e q u e n c e ( 5 ´ - 3 ´ ) 
 
Amplicon size 
    
Collagen Sense TCTGACTGGAAGAGCGGAGAG 125 bp 
(mRNA) antisense GGCACAGACGGCTGAGTAGG  
    
β-Actin Sense CTCTAGACTTCGAGCAGGAGATGG 164 bp 
(mRNA) antisense ATGCCACAGGATTCCATACCCAAGA  
    
GATA-3 Sense CCCGAGTACAGCTCTGGACTCTTC 118 bp 
(mRNA) antisense TCACACACTCCCTGCCTTCTG  
    
T-bet Sense AGAAGGCAGCATGCCAGGGAAC 228 bp 
(mRNA) antisense GCACTGCAGGCAGCCTCTGG  
    
IL-4 Sense CGTCCTCACAGCAACGAAGAACAC 142 bp 
(mRNA) antisense AAGAGTCTCTGCAGCTCCATGA  
    
IFN-γ Sense GGAGGAACTGGCAAAAGGATGG 108 bp 
(mRNA) antisense TGTTGCTGATGGCCTGATTGTC  
    
α-SMA Sense TGACAGAGGCACCACTGAACC 155 bp 
(mRNA) antisense TCCAGAGTCCAGCACAATACCAGT  
    
iNOS Sense CGCTACAACATCCTGGAGGAAGTG 114 bp
(mRNA) antisense ACTATGGAGCACAGCCACATTGA  
    
Arginase-2(Arg2) Sense GCCTGGCAATAGGTACCATTATCG 177 bp 
(mRNA) antisense CTGGCAGTTGTGGTACCTTGTC  
    
MCP-1 (CCL2) Sense GTGTTGGCTCAGCCAGATGC 118 bp 
(mRNA) antisense GACACCTGCTGCTGGTGATCC  
    
MIP-3α (CCL20) Sense ATCAACTCCTGGAGCTGAGAATGG 133 bp 
(mRNA) antisense ATGTACGAGAGGCAACAGTCGTAG  
    
CX3CL1 Sense GCAAGCGTGCCATTGTCCTG 110 bp 
(mRNA) antisense GGCAGCAGCCTGGTGATCC  
    
CCR2 Sense GGAGACAGCAGATCGAGTG 170 bp 
(genomic) antisense CATGACCCAAAGTAAGAACCAC  
    
CCR6 Sense TGTGCCAATTGCCTACTCC 399 bp 
(genomic) antisense GGCCTTGAGATGATGG  
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2.1.5 Antibodies 
2.1.5.1 Primary Antibodies 
Table 2.1.1 Primary Antibodies 
Antigen (target) Conjugate Usage Company 
CD3a PE-Cy7 Flow cytometry e-Bioscience 
CD4 APC Flow cytometry e-Bioscience 
CD8a PE Flow cytometry BD 
CD11b PE Flow cytometry e-Bioscience 
CD19 PerCp Flow cytometry BD 
CD25 PerCp Flow cytometry BD 
CD45.1 FITC Flow cytometry, IF BD 
CD45.2 APC Cy7 Flow cytometry BD 
CD115 PE Flow cytometry e-Bioscience 
Gr-1(Ly-6C) PerCP Flow cytometry BD 
Ly-6G FITC Flow cytometry BD 
NK1.1 PE Flow cytometry BD 
F4/80 Biotin Flow cytometry, IF BD 
IFN-γ PE Flow cytometry BD 
IL 4 PE Flow cytometry BD 
iNOS - Flow cytometry, WB BD 
Arginase - Flow cytometry, WB BD 
Collagen-I - IF Bio trend 
α-SMA - IF, WB Sigma 
GAPDH - WB Biogenesis 
CD115 Biotin Flow cytometry, MACS e-Bioscience 
CD11b - IF BD 
CD 8 Micro bead MACS Miltenyi biotec 
CD 19/ B220 Micro bead MACS Miltenyi biotec 
hTGFβ1 - Cell culture Santa Cruz Biotech 
 
IF- Immunofluorescence 
WB- Western Blot 
MACS- Magnetic activated cell sorting 
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2.1.5.2 Secondary Antibodies 
 
Table 2.1.2 Secondary antibodies 
Antigen (target) Conjugate Usage Company 
Biotin Streptavidin PE Cy7 Flow cytometry BD 
Rabbit Ig G Cy3 IF Jackson laboratories 
Mouse Ig G Horseradish peroxidase (HRP) Western Blot Santa Cruz 
Rat Ig G AF 488, AF 546,AF 594 IF Invitrogen 
Rat Ig G FITC Flow cytometry BD 
Biotin Streptavidin microbead MACS Miltenyi biotec 
 
2.1.6 Enzymes  
  
Collagenase Type IV (280 U/mg) Worthington (Lakewood, USA) 
Proteinase K recombinant (50U/mg) Roche 
  
2.1.7. ELISA Kit  
  
Mouse TGFβ1 BD biosciences 
  
2.1.8 Cytometric Bead array  
  
MCP-1 BD biosciences 
IL-6 BD biosciences 
  
2.1.9 Buffers and Solutions  
Agarose Gel 1% Agarose 
 0.00017 % Ethidium Bromide 
 in 1x TAE 
  
2x Blocking Buffer (FACS) 2% Mouse Serum 
 2% Rabbit Serum 
 2% Human Serum 
 2% BSA, all in sterile PBS 
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BSA Solution (30%) 30 g BSA 
 in 100 ml PBS 
  
Chloramine T Solution 0.6% Chloramine T 
 in Buffer B 
  
     Buffer A 3.4% NaOH 
 162 mM Citric Acid Monohydrate 
 881 mM Sodium Acetate Trihydrate 
 in Aqua Select 
 Adjust pH to 6.0 with Acetic Acid 
  
     Buffer B 60 ml Isopropanol 
 33 ml Aqua Select 
 39 ml Buffer A 
  
Collagenase Stock Solution 2% Collagenase 
 in RPMI 
  
Collagenase Working Solution 0.2% Collagenase 
 1% FCS 
 in HBSS 
  
Concanavalin A Working Solution 2 µg/ml Concanavalin A in PBS 
  
DEPC water 0.1% DEPC 
 in Aqua Select (autoclaved) 
  
EDTA 100 mM EDTA (pH 8.0) 
 in Aqua Select 
  
Ehrlich´s Reagent 3 g 4-Dimethylaminobenzaldehyde 
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 26 ml Isopropanol 
 5.7 ml 70% Perchloric Acid 
  
FCS-EDTA 10 mM EDTA in FCS 
  
Formalin Solution 1% Formaldehyde in PBS 
  
HBSS++ 0.06% BSA 
 0.3 mM EDTA in HBSS 
  
Haemalaun Solution 2 g Haematoxylin 
 0.4 g Sodium Iodate 
 100 g Aluminum Potassium Sulfate 
 100 g Chloral Hydrate 
 2 g Citric Acid 
 in 2000 ml Aqua Select 
  
Hydroxyproline Working Solution 0.1% cis-4-Hyroxy-D-Proline 
 in 50% Isopropanol 
  
Eosin Solution 1% Eosin 
 in 100 ml Aqua Select 
 1 drop of Acetic Acid (glacial) 
  
Ladewig Solution 2.5 g Anilin Blue 
 10 g Orange G 
 5 g Acidic Fuchsine 
 in 500 ml Aqua Select 
 i)  boil for 2 min 
 ii)  filter 
 iii)  add 40 ml Acetic Acid (glacial) 
Lysis Buffer   (for RBC) 1x Pharmlyse in Aqua Select 
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MACS buffer (degassed) HBSS 
 1.6% BSA 
 100 mM EDTA 
  
Paraformaldehyde  Solution (4%) 4 g Paraformaldehyde 
 in PBS 
  
Polyacrylamide Resolving Gel (10%) 4 ml Tris-HCl pH 8.8 
 1 ml 1% SDS 
 3.3 ml Acrylamide (30%) 
 1.7 ml Aqua Select 
 100 µl 20% APS 
 10 µl TEMED 
  
Polyacrylamide Stacking Gel (4%) 0.6 ml Tris-HCl pH 6.8 
 0.5 ml 1% SDS 
 0.7 ml Acrylamide (30%) 
 3.2 ml Aqua Select 
 50 µl 20% APS 
  
Real-Time Amplification PCR Mix 12.5 µl SYBR Green Mix 
 0.5 µl Forward Primer 10 µM 
 0.5 µl Reverse Primer 10 µM 
 in 9.5 µl DEPC H20 
  
PCR Amplification REDTaq Mix 12.5 µl REDTaq Ready Mix 
 1 µl Forward Primer 10 µM 
 1 µl Reverse Primer 10 µM 
 in 8.5 µl H20 
  
Reverse Transcription PCR Mix RNAse Inhibitor (2.86 U/µl) 
 Reverse Transcriptase (1.43 U/µl) 
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 dNTP Mix (2.86 mM) 
 in Reverse Transcriptase Buffer 
RIPA (Radio Immuno  
Precipitation Assay) Buffer 50 mM Tris-HCl pH 7.4 
 150 mM NaCl 
 1% NP40 
 0.5% Deoxycholic Acid 
 1 mM PMSF 
  
Rotiphoresis SDS Working Solution 1x Rotiphoresis SDS-PAGE Buffer 
 in Aqua Select 
  
RPMI++ 0.5% BSA 
 0.4% EDTA 
 in RPMI 
  
TAE Working Solution 1x TAE Buffer 
 in Aqua Select 
  
Tail Lysis Buffer 50 mM Tris-HCl pH 8.0 
 100 mM EDTA pH 8.0 
 100 mM NaCl 
 1% SDS 
  
Tissue Lysis Buffer 1 mM Sodium Orthovanadate 
 1 mM DTT 
Tablet 1 Protease Inhibitor Cocktail  
 1 mM PMSF 
 in 10ml RIPA Buffer 
  
Transfer Buffer (Western semi dry) Glycine 2.9 g 
 Tris 5.8 g 
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 20% SDS 1,85 ml 
 200 ml Methanol 
 make it up 1L with water 
 Adjust the pH 8.3 (HCl) 
  
Tris pH 6.8/pH 8.8 1 M Tris 
 in Aqua Select 
  
Triton Solution 0.1% TritonX-100 
 0.1% Trisodium Citrate Dihydrate 
 in PBS 
  
Tunel Enzyme label mix 5ul Tunel Enzyme  
 45ul Tunel Label Solution 
  
Tungstophosphoric Acid Solution 5% Tungstophosphoric Hydrate 
 in Aqua Select 
  
 
Weigert´s Iron Haematoxylin Solution A + Solution B 1:1 
  
Ferric Chloride Solution 29% Ferric Chloride in Aqua Select 
  
     Solution A 1% Haematoxylin 
 in Ethanol (Absolute) 
  
     Solution B 40 ml 29% Ferric Chloride 
 7.5 ml concentrated Hydrochloric Acid 
 in 950 ml Aqua Select 
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2.2.0 Animal experimental methods 
 
2.2.1.1 Animal breeding 
 
Animals were bred under standardized conditions following National Academy of 
Sciences (NIH publication 86-23 revised 1985) criteria in the animal research 
institute “Institut für Versuchstierkunde” of the University Hospital of the RWTH 
Aachen (UK Aachen). During breeding and the subsequent experiments a 12 hours 
light-dark rhythm, standardized temperature of 20-24°C and humidity of 50-60% was 
maintained by central air conditioning. Mice were housed in macrolon cages 
providing food and water ad libitum and were grouped up to 5-10 animals per cage. 
Biopsies of tail tips for genotyping were taken after ear marking and separation of the 
litter mates from the breeding couples.  
All studies were approved by the appropriate authorities according to the German 
legal requirements (Tierversuchsantrag 50.203.2-AC 5a, 30/06). 
. 
2.2.1.2 Animals 
 
The following mouse strains were used in this thesis: 
 
C57Bl/6 (B6) Wild Type Control Jackson Laboratory, Bar Harbor, Maine USA 
   
Ccr2-/- B6 mice deficient for CCR2  
 receptor  encoding gene kindly provided by Christian Weber, Aachen 
   
   
Ccr2-/-Ccr6-/- B6 mice deficient for CCR2 and kindly provided by Meriam Merad, New York 
 CCR6 receptors encoding genes  
   
C57Bl/6 Ptprc B6 mice with the congenic for Jackson Laboratory, Bar Harbor, Maine USA 
 CD45.1 marker  
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2.2.2. Acute carbon tetrachloride (CCl4) induced liver injury 
 
Mice received 50 μl of carbon tetrachloride (CCl4) via intraperitoneal injection with a 
20G needle. To provide a dose of approximately 0.6 ml CCl4 per kg body weight, the 
agent was diluted with corn oil in a ratio indicated in table 2.4. Control mice received 
pure corn oil. A single injection of 0.6 ml CCl4/kg body weight reliably induces an 
acute toxic liver injury. 
 
Table 2.2 Ratio of oil and CCl4 mix according to body weight 
 
Mouse weight range (g) CCl4 Volume (μl) Oil Volume (μl) 
       17-20     222    778 
       20-23     258    742 
       23-26     294    706 
       26-29     336    664 
 
2.2.3 Chronic liver injury and liver fibrogenesis induced by 
         carbon tetrachloride (CCl4) administration 
 
Mice received 50 μl of CCl4 twice a week via intraperitoneal injection (i.p) with a 20G 
needle. The dosage was determined as indicated in Table 2.4. Control mice received 
pure corn oil. CCl4 and oil was administered over a period of 6 weeks. The twice 
weekly application regimen is a chronic liver injury model resulting in significant liver 
fibrosis. 
 
2.2.4 Depletion of circulating monocytes 
 
For a transient depletion of circulating monocytes, mice received a single 
intravenous injection of 250 µl clodronate-loaded liposomes into the lateral tail vein 
with an Omnican syringe. A single injection of clodronate liposomes (Clo-lip) reliably 
depletes monocytes from the blood (depletion ≥ 95%) for upto 48 h. Control mice 
were injected with PBS-loaded liposomes. Clodronate-loaded liposomes were kindly 
provided by Nico van Rooijen, Free University Amsterdam, and The Netherlands. 
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2.2.5 Nucleic Acids 
 
2.2.5.1 Isolation of RNA from liver samples 
 
All tools and surfaces were cleaned with RNAse Zap before and during usage in 
order to inactivate RNAses. All centrifugation steps were conducted at 4°C. Liver 
samples were taken out of -80°C storage and were mixed with 1.6 ml of peqGOLD 
TriFast. Samples were shredded with an Ultra Turrax and incubated for 10 min at 
room temperature under occasional agitation. Chloroform (320 µl) was added to 
each sample, which were vortexed to ensure proper mixing and incubated on ice for 
5 min. Vials were shaken occasionally. After incubation, samples were centrifuged at 
15000 g for 15 min. There will be three phases; the upper supernatant phase 
carefully pipetted out and was mixed with an equivalent volume of isopropanol. 
Samples were gently shaken and incubated for 10 min at 4°C, then centrifuged at 
15000 g for 10 min. The pellet was washed twice with 70% ethanol (6 min at 6000 
g), air-dried and dissolved in 90 µl 0.1% DEPC water. RNA purity and concentration 
were determined with a photometer. The samples were diluted 1:30 with aqua select 
and the OD (optical density) was measured at 260 and 280 nm. Water was used as 
a blank, since the RNA was diluted in water. A ratio of E260/E280 between 1.8 and 
2.0 accounted for pure RNA. 
 
2.2.5.2 Isolation of DNA from tail tips 
 
Tail tips were incubated for 2-3 h in 750 µl Tail Lysis Buffer plus 25 µl Proteinase K 
at 56°C. The lysate was vortexed and spun. An equivalent volume of isopropanol 
was added to 500 µl supernatant, the samples were vortexed and incubated for 10 
minutes at room temperature and centrifuged again. All centrifugation steps lasted 
10 min and were carried out at 20000 g at room temperature. The pellet was washed 
twice with 70% ethanol, air-dried and resuspended in 200 µl aqua select. 
 
2.2.5.3 cDNA sythesis  
 
 All steps were performed on ice if not stated otherwise. The equivalent of 2 µg RNA 
was mixed with 2 µl of a random hexamer primer mix, and the desired reaction 
volume of 13 µl was adjusted with water. In order to eliminate secondary structures 
of the RNA molecules, the samples were incubated for 10 minutes at 65°C. 
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Afterwards, 7 µl of Reverse Transcription PCR Mix were added to each sample. The 
RT reaction was done as follows: 
 
Table 2.3 Reverse transcription protocol 
  
Step Duration Temperature Number of cycles
Warm up 10 mins 25oC 1 
Reverse transcription 60 mins 50oC 1 
Denaturation   5 mins 85oC 1 
End step     ∞ 4oC  - 
 
During the amplification phase, the random primers bound to the primary RNA 
structure and served as a template for the polymerase. The whole transcriptome was 
translated into complementary DNA (cDNA), because the random primers bound 
ubiquitously. To separate the RNA/cDNA double helices, samples were heated after 
reverse transcription. The cDNA samples were diluted 1:3 in DEPC H2O and stored 
at -20°C. 
 
2.2.5.4 Real Time PCR  
 
For real time amplification, 2 µl of cDNA were added to 23 µl Real Time Amplification 
PCR Mix and run in duplicates according to the following PCR protocol. For 
reference, a house keeping gene transcript was amplified. 
 
Program for the Real time PCR 
 
Procedure      Duration        Temperature    Number of Cycles 
Warm-up 2 min 50°C 1 
     
Hot start 15 sec 95°C 1 
    
Amplification 1 min 60°C 40 
    
Amplification 1 min 60°C 1 
    
Melting Curve 15 sec 95°C 1 
    
Melting Curve 30 sec 60°C 1 
     
Melting Curve 15 sec 95°C 1 
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In order to melt double-stranded DNA, samples were heated prior to each 
amplification phase. Then the temperature was lowered to match the annealing 
temperature of the primers. Sense and antisense primers bound specifically to their 
complementary target sequence in the primary cDNA structure, and the area defined 
by the upstream and downstream primer was multiplied. SYBR Green only emits 
fluorescence when bound to double-stranded DNA. Thus, after each cycle, the 
fluorescence intensity was measured as a function of DNA amplification. When the 
fluorescence emitted by bound SYBR Green rose above the level of background 
fluorescence, it reached detection level. The number of this threshold cycle is the Ct 
value. For a relative quantification of the amplified targets, the ∆Ct method was 
employed. The Ct values of the samples of interest and a control sample were 
normalized against an appropriate housekeeping gene and then compared; using 
the Pfaffl method, gene expression is quantified: 
 
                                                 ∆Ct = Ct Target – Ct Reference 
                                               ∆∆Ct = ∆Ct control - ∆Ct Treated 
                               Fold of change = 2∆∆Ct  
                                 Normalization = (Etarget) ∆Ct target (control-treated)/ (ERef) ∆Ct Reference (control-treated) 
 
The Real Time System was operated with the software SDS V.1.3.1. 
 
2.2.5.5 End Point PCR with genomic DNA 
 
In order to validate the genotype of the used mice strains, PCR was performed 
routinely with genomic DNA isolated from mice tail tips. Using either the primer set 
for CCR2 or CCR6, 23 µl of PCR Amplification REDTaq Mix were mixed with 2 µl of 
DNA. Annealing temperature was 58°C. 
 
Table 2.4 PCR Program 
 
Procedure  Duration Temperature Number of cycles 
Melting 5 mins 95oC    1 
Denaturation 45 sec 95oC   35 
Annealing 45 sec 58oC   35 
Extension 45 sec 72oC   35 
Final extension 5 mins 72oC    1 
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The amplified samples were loaded onto a 1% agarose gel containing ethidium 
bromide (EtBr) and separated by applying 60 V for 45 min. EtBr attached to the 
minor groove of the DNA double helix and thereby accumulated in areas of high 
DNA concentration. When exposed to UV light, EtBr starts fluorescing. Since the 
PCR amplicon was the most abundant fragment of DNA in the gel, EtBr preferentially 
bound to it and makes it visible under UV light. A lack of expected amplicon size 
indicated the absence of a gene, which indicates an efficient gene knockout and wild 
type animals were used as positive controls. 
 
2.2.6 Proteins 
 
2.2.6.1 Isolation and quantification of protein from liver samples 
 
Liver samples were taken out of -80°C storage and were manually homogenized in 
500 µl tissue lysis buffer containing protease inhibitor cocktails on ice. The 
homogenate was centrifuged for 10 min at 10000 g, and the supernatant was 
collected. The protein concentration was assessed with a Bradford assay, using the 
following solution: 
 
200 µl Bio-Rad Protein Assay solution  
798 µl aqua select  
    2 µl 1:5 diluted supernatant 
 
The Bio Rad Protein Assay solution contained Coomassie Brilliant Blue (CBB). In the 
presence of aromatic aminoacids, CBB is reduced and shifts its absorbance 
maximum to 595 nm. Thus, the intensity of the blue colour increases as a function of 
protein concentration. To generate a standard dilution curve as a reference, the 
equivalent of 0 µg, 1 µg, 2 µg, 4 µg, 6 µg, 8 µg and 10 µg BSA was added to the 
Protein Assay/Water solution. After 10 min of incubation at room temperature, all 
samples measured in duplicates with a spectrophotometer at 595 nm, using the 
operating software KC-4 v4.6. The protein concentrations were deduced 
automatically from the BSA standard curve. 
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2.2.6.2 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS- 
            PAGE) 
 
In order to visualize specific proteins in the heterogeneous protein extract, a Sodium 
Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) was performed. 
Proteins loose their native conformation in the presence of β-mercaptoethanol and 
by boiling the sample at 100oC for 5 mins together with the loading buffer which 
contains SDS and β-mercaptoethanol. The proteins are loaded onto a gel that 
consists of 2 different phases, both containing sodium dodecyl sulfate (SDS). 
Negatively charged SDS binds unspecifically to proteins, further denaturing them 
and turning them into polyanionic. When voltage is applied, the samples first migrate 
through the stacking part of the gel, driven by their negative charge. The stacking 
phase is slightly acidic (pH 6.8) and compresses the protein front into a dense line. 
Once the focused samples reach the resolving gel (pH 8.8), their migration speed 
becomes a function of their size. Due to higher acrylamide content, the gel slows 
down bigger proteins and allows quick migration of smaller ones. When the voltage 
is cut after a certain period of time, the heterogeneous protein sample has been 
resolved into distinct bands of equally sized molecules. Their molecular weight can 
be deduced from a standardized marker. 
 
In preparation of the SDS-PAGE, Polyacrylamide Resolving Gel (5 ml) was applied 
to a glass mould and covered immediately with 200 µl n-butanol to flatten the surface 
and prevent oxidation, which interferes with polymerization. After cross-linking of the 
gel components, n-butanol was flushed out with water, and 2.5 ml Polyacrylamide 
Stacking Gel were added. The electrophoresis chamber was filled with 1 l of 1x 
Rotiphoresis SDS-PAGE running buffer. The equivalent of 30 µg protein sample as 
determined by a Bradford assay was mixed with loading buffer and water to a final 
volume of 15 µl and loaded to the wells. For reference, 5 µl of protein standard were 
loaded into a separate well. A voltage of 60 V was maintained during the stacking 
phase and increased to 120 V upon entering of the samples into the resolving gel. 
The applying voltage was stopped when the protein front reached the bottom of the 
gel. 
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2.2.6.3 Western Blot (Semi-dry Gel Transfer) 
 
Prior to the semi dry blotting procedure, 3-4 pieces of Whatman papers at the size of 
the gel were soaked in transfer buffer and placed in the blotting chamber. A sheet of 
nitrocellulose transfer membrane was rinsed with water and put on top of the stack. 
After removal of the stacking gel, the resolving gel was overlaid to the membrane. In 
addition 4 layers of Whatman papers were drenched in transfer buffer and placed 
onto the gel. A current of 68 mA (A2x0.8) per gel was applied to the blotting chamber 
and maintained for 45 min. Driven by the voltage, the protein samples were 
transferred from the gel to the membrane. After blotting, the membrane was stained 
with Ponceau solution to verify protein integrity. Ponceau was removed by washing 
with 1% TBST. To allow specific antibody targeting, the membrane was blocked for 1 
h in 1% TBST with 2% milk powder at room temperature. The primary antibody 
(Monoclonal Anti α-Smooth Muscle Actin) was diluted 1:1200 in 1% TBST with 2% 
milk powder and applied to the membrane. After 1 h of incubation at room 
temperature, the membrane was washed 3 times with 1% TBST in order to loose 
unbound antibodies.  
 
To visualize the protein bands, the membrane was exposed to a 1:1 mix of ECL 
Detection Reagent 1 and 2, placed into a cassette and covered with a sheet of film. 
The enzyme HRP, bound to the secondary antibody (horseradish peroxidase) 
catalyzes a chemiluminescence-emitting reaction that exposed the film in those 
areas where secondary antibody was bound. After the desired exposure time 
(usually between 5 seconds and 5 minutes), the film was transferred to a developing 
machine. In order to verify the target protein expression compared to a 
housekeeping protein marker, the membrane was stripped of the attached antibodies 
by an overnight incubation with 1% TBST or using a commercially available stripping 
buffer for 20 mins at room temperature. Blocking was performed as before and 
followed by incubation with an antibody directed against GAPDH (Monoclonal Anti-
GAPDH) in a 1:15000 dilution in 1% TBST with 2% milk powder. The remaining 
steps were carried out as described above. 
 
 
2 Materials and Methods                           
 
 37
2.2.6.4 ELISA  
To quantify the total TGFβ1 levels from the fibrotic livers, protein samples were 
prepared as described in section 2.2.6.1. ELISA plate (96 wells) was coated with 
TGFβ1 capture antibody at 1:250 dilutions as described by the manufacturer for over 
night at 40C. After incubation, plate was washed for 3 times with a freshly prepared 
wash buffer containing 0.05% of Tween-20 in PBS. Plate was blocked for 1 hour at 
room temperature with 10% fetal calf serum (FCS) in PBS. 30 ug protein samples 
were used along with standards and incubated for 2 hours at room temperature. 
After incubation, plate was washed atleast for 4 times with wash buffer containing 
0.05% of Tween-20 in PBS. Detection antibody is added at 1:250 dilutions and the 
plate was incubated for 1 hour at room temperature. Plate was washed for 5 times 
as like before and the substrate was added to each well and further incubated for 10 
minutes at room temperature in dark. In order to stop the reaction 50 µl of 2N H2SO4 
was added to the wells and the absorption was measured at 450 nm in duplicate with 
a spectrophotometer, using the operating software KC-4 v4.6. Four parametric 
logistic model of analysis of the standard TGF β1 and the samples were performed 
to measure the total TGF β1 levels. 
 
2.2.7 Leukocytes and tissues 
 
2.2.7.1 Isolation of blood and splenic leukocytes 
 
All centrifugation steps were carried out at 4°C and 470 g if not mentioned otherwise. 
After performing experiments (e.g. induction of an acute or chronic liver injury) as 
indicated in the specific conditions and specified time-points, the mice were 
sacrificed by applying CO2 in a closed chamber. They were opened with a posterior 
to anterior incision across the abdomen forefront. Blood was taken by cardiac 
puncture with a syringe filled with 100 µl of 100 mM EDTA and fitted with a 27G 
needle. Approximately 200 µl of the collected blood were transferred to a separate 
tube for collection of plasma (see section 2.2.9.1), the remaining samples were 
added to 3 ml of 1x RBC lysis buffer. The red blood cell lysis was stopped after 10 
min of incubation on ice by addition of 10 ml HBSS++. The cells were centrifuged for 
5 minutes; the pellet was resuspended in 10 ml of RPMI++, as a washing step and 
the samples were centrifuged again. The final pellet was taken up in 200 µl blocking 
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buffer. The spleen was excised and disrupted in HBSS++. The resulting cell 
suspension was filtered through a 70 µm cell strainer and centrifuged for 5 min. The 
pellet was resuspended in 1 ml 1x RBC lysis buffer, and the red blood cell lysis was 
stopped after 5 min with 5 ml of HBSS++. The cells were spun again for 5 min, and 
the pellet was taken up in 200 µl blocking buffer. 
 
2.2.7.2 Isolation of intrahepatic leukocytes and tissues 
 
The liver was perfused in situ by injection of 20 ml PBS directly into the heart using a 
20G needle. After excision of the liver, the gallbladder was removed. Small pieces of 
liver samples were immediately flash frozen in liquid nitrogen for further analysis of 
the transcriptome (2.2.5), protein expression levels (2.2.6) and hydroxyproline 
content (2.2.9) and the samples were later transferred to -80°C for long-term 
storage. Samples for immunohistochemistry (2.2.8) were embedded in Tissue-Tek 
(OCT) and stored at -20°C. 
 
A further piece of liver was collected and fixed in 4% PFA and kept at 4°C for 
Haematoxyline/Eosine staining (2.2.8.2). Ladewig and Sirius red staining. The 
remaining parts of the liver were transferred to a 6-well-plate containing 5 ml of 
collagenase working solution. After carefully mincing the liver, the samples were 
collagenase-digested by incubating at 37°C for 45 min.  
 
Subsequently, the samples were further homogenized into a single-cell suspension 
by passing through a 20G needle until no macroscopic pieces remained, and 
eventually filtered through a 70 µm cell strainer. 200 μl liver samples were collected 
for total leukocyte count (see table 2.6). In order to separate leukocytes from 
hepatocytes and cellular debris, 5 ml of Lymphocyte LSM 1077 were carefully 
layered under the sample through a Pasteur pipette. The gradient was centrifuged 
for 20 min at 22°C at 755 g, without applying brake to the centrifuge in order to avoid 
shearing and to keep the gradient intact. The resulting interphase layer of 
leukocytes, floating on top of the Lymphocyte LSM 1077 phase, were carefully 
isolated and centrifuged for 5 minutes at 1400 rpm at 4oC. The resulting cell pellet 
was washed with RPMI++ and then resuspended in 200 µl blocking buffer. 
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2.2.7.3 Surface antibody staining of blood and liver leukocytes 
 
Blood and liver leukocyte samples were split. Each group was incubated with a 
different set of monoclonal antibodies (Table 2.6) for 20 min at 4°C at a final antibody 
dilution of 1:200. 
 
   Table 2.5 Antibody panel for the cell surface staining 
Sample groups Antibody panel 
 
Blood 1 CD115 PE, Gr-1 PerCp 
Blood 2 CD4 APC,CD8 PE and CD19 PerCp 
Liver 1 CD45 APC Cy7,CD11b PE, F4/80biotin-streptavidin PE Cy7,CD8a FITC 
Liver 2 CD45 APC Cy7, CD4 APC, CD25 PerCp,NK1.1 PE 
Liver 3 CD45 APC Cy7 (without gradient) 
 
Each antibody bound specifically to its corresponding cellular surface antigen, thus 
labeling only those cell types that bore the respective marker. After incubation, the 
samples were centrifuged, and the supernatant was discarded. The cells were 
washed with 200 µl HBSS++ and spun again. The samples of Liver 1 were incubated 
for a second time as described before, this time with PE-Cy7-Conjugated 
Streptavidin, targeting the biotinylated primary antibody (Anti-F4/80). Finally, all 
pellets were fixed in 250 µl of 1% formalin and subjected to Fluorescence Activated 
Cell Sorting (FACS, 2.2.7.5). 
 
2.2.7.4 Intracellular antibody staining of liver leukocytes 
 
Intrahepatic leukocytes were isolated as described under section 2.2.7.2. Cells were 
resuspended in 5 ml of RPMI medium containing 10% FCS Penicillin/Streptomycin 
mix. For stimulation of cells, ionomycin and phorbol-12-myristate-13-acetate (PMA) 
were added in a final concentration of 500 ng/ml and 50 ng/ml respectively. 
Ionomycin is an ionophor, a lipid-soluble molecule that transported PMA across the 
lipid bilayer of the cell membrane. PMA is a diester of phorbol and a potent activator 
of the signal transduction enzyme Protein Kinase C (PKC). Activation of PKC led to 
increased cytokine production. In order to prevent exocytosis of the cytokines 
produced by the activated leukocytes, cells were additionally exposed to 10 µg/ml of 
Brefeldin A.  
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Brefeldin A, interferes with vesicular trafficking of the Golgi apparatus and hamper 
exocytosis. Incubation under these conditions lasted for 2 h at 37°C. Afterwards, the 
cells were washed with RPMI medium containing 10% FCS Penicillin/Streptomycin 
mix, centrifuged at 1500 rpm for 5 mins at 4oC. The resulting cell pellet was 
resuspended in 200 µl blocking buffer preferentially with Brefeldin A. Selected 
antibody sets were added to the samples for surface staining in a dilution of 1:200 
per antibody (Table 2.7) and were incubated for 20 minutes at 4oC.Surface stained 
cells were fixed with 200 μl of 1% formalin in PBS. This surface labeling allowed later 
identification of CD4+ T cells and CD11b+F4/80+ cells.  
 
In order to prepare the cells for intracellular staining, they were incubated for 20 min 
at room temperature in 200 µl Cytofix/Cytoperm, a fixative and membrane 
permeabilizer. After washing twice with 1x BD Perm/Wash buffer, the pellets were 
resuspended in 300 µl Perm/Wash buffer. The suspensions were split into 3 sets of 
each 100 µl aliquots and each aliquot was incubated with one of the antibodies from 
the intracellular staining set, respectively, in a 1:200 dilution (Table 2.7). In order to 
permit antibody diffusion into the cells, the samples were incubated for 30 min at 
4°C. Finally, they were washed 2 times in Perm/Wash buffer and resuspended in 
200 μl of PBS + 1% BSA to allow membrane closure. All samples were subjected to 
FACS analysis (2.2.7.5) using the BD FACS Canto II. 
 
Table 2.6 Antibody panels for surface- and intracellular staining 
Staining  Antibody panel 
Surface staining Liver 1 CD11b PE, F4/80 PE-Cy7,CD45 APC Cy7 
Surface staining Liver 2 CD4 APC,CD45 APC Cy7  
Intracellular staining Liver 1 Arginase, iNOS FITC, IgG  FITC (isotype control) 
Intracellular staining Liver 2 IL4 PE, IFNγ PE, IgG PE (isotype control) 
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2.2.7.5 Fluorescence Activated Cell Sorting (FACS) 
 
The FACS Canto II (BD) is a 6 color flow cytometer with two lasers (blue, 488 nm; 
red, 638 nm). It can reliably analyze up to 8 parameters per cell, being 6 different 
fluorescence labels plus cell size (Forward scatter, FSC) and granularity (Side 
scatter, SSC) at a cell count rate of up to 10,000 events per second.  
The cells from the sample are aligned in a stream of liquid, passing the excitation 
lasers and emission detectors one by one. Cells of different size and different 
granularities scatter the light from the lasers in different ways and detected by the 
fluorescent detectors which yields two specific parameters per cell. Additionally, 
respective surface markers or intracellular molecules of each cell can be labeled with 
antibodies which are conjugated to a fluorescent dye. The specific emission 
spectrum of each dye allows further subdivision of the analysed cell populations 
based on the array of markers each cell presents. The resulting data for every 
individual cell are plotted in a graphic representation according to the parameters 
defined for the X- and Y-axis. The FACS Canto II was operated using the FACS Diva 
Software Version 6.0.3. The final recorded FCS data files were exported and the 
results were analysed with FlowJo software version 7.1.2.  
 
2.2.7.6 Isolation of monocytes, lymphocytes for adoptive transfer  
 
For monocyte and lymphocyte isolation procedures, C57Bl/6 mice with the congenic 
CD45 receptor CD45.1 were used for all adoptive transfer experiments for efficient 
tracking inside the recipient animals. For isolation of monocytes, bone marrows were 
used and for lymphocytes such as CD8+ T, CD19+ B cells spleens were used. 
Femur, tibia and spleen were isolated from the CD45.1 transgenic mice. Muscle was 
removed from the tibia and femur gently by pealing with facial tissue papers and was 
flushed with 5 ml of DMEM containing 0.5% BSA, 2 mM EDTA using a syringe with a 
27G needle. Spleen were minced into small pieces and smashed through a 70 μm 
filter. Cells were centrifuged at 1200 rpm at 4oC and the cell pellet from the spleen 
was treated with 2 ml of RBC lysis buffer and the pellets were washed with DMEM 
medium with 0.5% BSA and 2mM EDTA. Cells were counted and resuspended in 
FACS blocking buffer approximately 400-600 μl based on their density. Samples 
were collected at each step for counting and for FACS analysis. For monocyte 
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isolation, bone marrow cells were incubated with CD115 biotinylated antibody at 1:20 
ratio to the volume of the blocking buffer.  
 
For isolating CD8+ or CD19+ cells, splenic cells were incubated with CD8 MACS 
antibody or B220 MACS antibody respectively with 1:20 ratio to the volume of the 
blocking buffer in which they were resuspended. Cells were incubated for 20 mins at 
4oC. After incubation, cells were resuspended and washed with 10 ml of MACS 
buffer. For isolating monocytes, secondary anti-streptavidin MACS antibody was 
used at 1:40 ratio and further incubated for 15 minutes at 4oC. Finally cells from 
spleen and bone marrow were washed with MACS buffer and centrifuged at 1200 
rpm for 10 mins at 4oC; the resulting cell pellet was gently resuspended in 6 ml 
MACS buffer gently and applied through calibrated Miltenyi LS columns under a 
strong magnetic field. Columns were washed 3 times with 3 ml of MACS buffer at 
each step and finally the purified cells were collected by positive selection by 
removing the columns from the magnetic field and flushed with MACS buffer. Cell 
samples were collected for FACS in order to check the purity. 
 
2.2.7.7 Monocyte adoptive transfer experiment 
 
CD45.1+ C57Bl/6 mice were used as donors for monocyte transfer experiments. 
Monocytes were isolated from the bone marrow of femur and tibia of the donor mice 
by MACS as described in the section 2.2.7.6. Congenic CD45.2+ C57Bl/6 or CD45.2+ 
Ccr2-/-Ccr6-/- recipient mice were injected intravenously (i.v) 1-2 million monocytes or 
PBS as controls during either the first 3 weeks of CCl4 treatment or during the last 3 
weeks of CCl4 treatment. Mice were sacrificed after 6 weeks of CCl4 treatment and 
the liver samples were taken and analyzed further. 
 
2.2.7.8 Co-culture experiments 
 
The continuous cell line GRX having myofibroblastic characteristics was obtained 
from the Rio de Janeiro Cell Bank (PABCAM, Federal University, Rio de Janeiro, 
Brazil) and cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% FCS, 4 mM L-Glutamine, and 10 IU Penicillin/Streptomycin per ml medium. 
For co-culture experiments, GRX cells were platted into 6-well dishes and cultured 
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for 24 h at 37oC with 5% CO2. Then, the medium was renewed and the cells were 
either (i) left untreated, (ii) stimulated with 5 ng/ml recombinant human TGFβ1 (R&D 
Systems, Minneapolis, MN), (iii+iv) co-cultured with Gr-1hi bone marrow monocytes 
in the presence or absence of a polyclonal affinity purified antibody raised against 
human TGFβ1 (v+vi) co-cultured with CD11b+F4/80+Gr-1+ liver monocytes in the 
presence or absence of the TGF- β1-specific antibody, (vii) Co-cultured with 
CD19+/B220+ splenic B-cells, or (viii) co-cultured with CD8+ splenic cytotoxic T cells. 
Murine immune cells were isolated from WT mice 48h after single CCl4 i.p. injection 
by MACS as described in section 2.2.4.7. A purity >90% was ensured by FACS 
analysis. The cells were co-cultured for 48 h at 37oC with 5% CO2, and RNA was 
isolated for quantitative real-time PCR as described in section 2.2.5.3. 
 
2.2.8 Microscopy 
 
2.2.8.1 Immunohistochemistry 
 
Tissue Tek-embedded liver samples were cut into 5 µm-thick slices using a cryostat 
with an ambient temperature of -20°C. Slices were mounted on glass slides and 
stored at -80°C until further use. Prior to the immunostaining, liver sections were 
fixed with 4% PFA for 10 minutes and washed 3 times with PBS containing 0.02% 
sodium azide for 3 minutes between each washing step.  
 
Tissue slices were either blocked with PBS containing 0.02% sodium azide and 
0.2% BSA or PBS with 1% mouse serum and 0.02% sodium azide. CD11b antibody, 
CD45.1 FITC antibody or Collagen-I antibody were diluted in PBS with 1% mouse 
serum at 1.200 and 1.300 ratios respectively. Antibodies were incubated for 1 hour 
either at room temperature or 4oC over night in a humid chamber. After incubation, 
slides were washed 3 times with PBS containing 0.02% sodium azide. Incase of 
CD11b and Collagen-I antibodies a secondary antibody labeled with FITC and Cy3 
respectively, was added and further incubated for 45 minutes at same conditions like 
before. Slides were washed with PBS, air dried and mounted with DAPI. Pictures 
were taken with a Zeiss fluorescence microscope using AxioVision 4.6 software 
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2.2.8.2 Histology 
 
All histological samples were prepared by the Department of Pathology at University 
Hospital Aachen. Samples were taken out of 4% PFA storage medium, embedded in 
Paraffin resin, cut to slices with an ultra microtome (at a thickness of 1-2 µm) and 
stored at room temperature. 
 
2.2.8.2.1 Haematoxylin/Eosin (H&E) staining 
 
H&E staining allows a microscopic assessment of the extent of tissue damage, 
because it visualizes alterations of tissue integrity. In preparation of staining, slices 
were warmed for 30 min at 60°C. They were immersed 3 times in Xylol, which 
served as a solvent for the dyes. Afterwards, they were briefly exposed to a 
descending dilution series of ethanol (100%, 96%, and 70%) and incubated for 5 min 
in aqua select. Samples were immersed in Haemalaun Solution for 5 min and then 
rinsed with tap water. Haemalaun Solution gave the cytoplasm a reddish color. To 
stain the nuclei, the slices were incubated with 1% Eosin for 5 min and then exposed 
to an ascending dilution series of ethanol (10 sec with 70%, 1-3 min with 96%, 2 
times for 5 min with 100%). Finally, the samples were immersed 3 times in Xylol. 
Slices were examined with a Leica bright field microscope. Pictures were taken with 
the DS2MV camera from Nikon. 
 
2.2.8.2.2 Ladewig Staining 
 
Collagen-specific Ladewig staining allows an assessment of the extent of fibrosis, 
because it renders collagen visible under a polarized light. Prior to staining, slices 
were immersed 3 times for 10 min in Xylol, which served as a solvent for the 
Ladewig dye. They were exposed to a descending dilution series of ethanol (100%, 
96%, 70%, 3-5 min each) and incubated for 5 min in aqua select. Subsequently, the 
samples were incubated for 5 min in Weigert´s Iron Haematoxylin, which was 
obtained by mixing Solution A and B in a ration of 1:1. Slices were rinsed 3 times for 
5 min with tap water and then exposed to 5% Tungstophosphoric Acid Solution for 3 
min. They were briefly washed with tap water and with aqua select. After immersion 
in 1:1-diluted Ladewig Solution for 5 min, they were again washed with aqua select 
and subjected to an ascending ethanol dilution series (10 sec at 70%, 1 min at 96%). 
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Finally, the slices were exposed to isopropanol (2 times for 5 min each) and 
immersed 3 times for 5 min in Xylol. Slices were examined with a Leica bright field 
microscope. Pictures were taken using the DS2MV camera from Nikon. 
 
2.2.9 Further biochemical analyses 
 
2.2.9.1 Aminotransferase activities in serum 
 
Transaminases like alanine aminotransferase (ALT) are enzymes catalyzing the 
reversible conversion of α-keto acids into amino acids in the liver. The plasma/serum 
activity of ALT is qualified as a specific marker for liver damage, since ALT is 
released from the cytoplasm of damaged hepatocytes. For aminotransferase 
analysis, animal blood was drawn. After spinning at 11050 g for 10 min at 4°C using 
a table top Eppendorf centrifuge, plasma was recovered and stored at -80°C until 
used for measuring of aminotransferase activities. Enzymatic activity was 
determined according to the IFCC method. All compounds of the enzymatic reaction, 
including L-Alanine/L-Aspartate, α-Ketoglutarate, Lactate dehydrogenase, Malate 
dehydrogenase and NADH were provided by mixing ALT detection reagent R1 and 
R2. Expected products of the enzymatic reaction were L-Glutamate+Pyruvate and 
respectively L-Glutamate+Oxalacetate. Subsequent reduction of 
pyruvate/oxalacetate by lactate dehydrogenase/ malate dehydrogenase, 
respectively, caused an oxidation of NADH to NAD+, which resulted in dye shifts and 
in change of absorbance. The kinetics was measured bichromatically at 340 and 700 
nm. Measurement was performed in the clinical routine laboratories of the UK 
Aachen. 
 
2.2.9.2 Hydroxyproline Assay 
 
Hydroxyproline is a cyclic amino acid and a major building block of collagen. An 
increase in total Hydroxyproline content in tissue samples is an indicator of the 
increased deposition of collagen fibers. In this assay, the total liver Hydroxyproline 
was measured biochemically by OD determination.Samples were taken out of -80°C 
storage and weighed. For every milligram of liver tissue 20 µl of 6 N hydrochloric 
acid (HCl) was added and incubated for 16 h at 110°C. The disintegrated samples 
were filtered through a whatmann filter paper. 15 µl of Liver hydrolysate was mixed 
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with 15 µl methanol, and the samples were evaporated to dryness in a speedvac 
pump from Eppendorf. For standard, a 100μg/ml stock of Hydroxyproline was serially 
diluted with different concentrations, starting with 12.8 µg/ml cis-4-Hydroxy-D Proline 
in 50% isopropanol. Sequential dilution in appropriate amounts of 50% isopropanol 
yielded a series of standard concentrations ranging from 12.8 µg/ml to 0.8 µg/ml. 
Additionally, a blank reference of 50% isopropanol was provided.  
 
After drying by speed vac, the pellet was resuspended in 50% isopropanol and 
vortexed vigorously. 50 µl of sample or standards were mixed with a fresh 100 µl 
0.6% Chloramine T Solution, which further oxidized Hydroxyproline. Tubes were 
vortexed and incubated for 10 min at room temperature. Afterwards,100 µl of freshly 
prepared Ehrlich´s Reagent was added, the samples were vortexed and subjected to 
incubation for 45 min at 50°C with constant vortexing. When exposed to Ehrlich´s 
Reagent, oxidated Hydroxyproline formed a pyrrole-type chromophore with λmax at 
570 nm and the absorption was measured in duplicate with a spectrophotometer, 
using the operating software KC-4 v4.6. Linear regression model of analysis of the 
Hydroxyproline standard yielded the linear equation y=ax+b, which was converted 
into x= y-b/a. The slope (a) and the intercept on the y-axis (b) were used to 
normalize the measured OD values (y). The normalized values (x) were multiplied by 
a factor 1.333, which yielded the amount of Hydroxyproline in µg of total 
hydroxyproline per gram of liver tissue. 
 
2.2.10 Statistics 
 
All data are presented as mean ± SD (Standard Deviation). Statistical analysis was 
performed using Microsoft Excel. The differences between the groups were 
assessed by means of a two-sided unpaired Student t test, which was used to 
determine statistical significance between knockout and wild type samples. 
Differences were considered significant when p-values were below 0.05. 
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3.1 Liver injury and Immunopathogenesis 
 
Many causative agents can lead to liver damage or liver failure in human patients. 
Chronic viral hepatitis, alcoholism and metabolic disorders rank amongst the top in 
Europe and North America. Although Hepatitis B or Hepatitis C viruses or alcohol 
directly affects the hepatocytes but the liver damage will be critically modulated by 
the infiltrating leukocytes (1, 18, 19). The persistence of the hepatotoxic agent and on 
going immune cell activations is a major factor which determines the fate of the 
disease either towards progression or regression of liver injury/fibrosis. 
 
It has been aimed at characterizing the leukocyte populations, especially the 
monocyte subsets which infiltrate the injured liver; therefore Carbon tetrachloride 
(CCl4) was used to induce either acute or chronic liver injury and assessed the injury 
using different techniques and parameters. Carbon tetrachloride (CCl4) is a well 
known experimental hepatotoxic agent and is believed to mimic toxic liver injury (e.g. 
alcoholic or drug induced) in humans (102,103). 
 
3.1.1 Acute liver injury by CCl4 and leukocyte migration into the liver 
 
To elucidate the role of monocyte subset infiltration following liver injury, wild type 
(WT) mice with a C57Bl/6 genetic background were injected 0.6 ml/kg dosage of 
CCl4 (Table 2.2) intraperitoneally (i.p). Liver damage was analyzed at different time 
points such as 0h, 4h, 24h, 48h, 72h and 120h.  
 
CCl4 administration resulted in necrosis around the hepatic periportal regions with 
maximal damage at the 24h and 48h time points (Figure 4: A) which was reflected by 
the serum transaminase activities as well (Figure 4: B).Conventional pathological 
examination by H&E staining and FACS analysis revealed a massive influx of 
leukocytes into the injured liver, which peaked at 24h and 48h time points (Figure 4: 
A and Figure 4: C) respectively. 
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Figure 4: Liver pathology and Liver infiltrating leukocytes after CCl4-induced injury (A) 
Conventional Haematoxylin Eosin staining reveals CCl4 mediated hepatotoxicity followed by leukocyte 
infiltration around the periportal regions.(B) Kinetics of serum ALT activity after single administration 
of CCl4 via i.p. (C) Kinetics of total liver infiltrating leukocytes after CCl4 mediated injury analysed by 
FACS. Data is expressed as the mean ± SD from at least 3 independent experiments (n = 5 animals 
per group)   
 
 
3.1.2 Monocyte infiltration into the injured liver 
 
To characterize the monocyte recruitment during CCl4 mediated liver injury, real time 
gene expression studies (2.2.5.4)were performed for the chemokine ligands relevant 
for monocyte attraction such as MCP-1 (CCL2), MIP-3α (CCL20) and CX3CL1 
(fractalkine). Interestingly the major monocyte chemoattractant MCP-1 was 
significantly up-regulated at mRNA level over 100-fold (Figure 5) at 48h after CCl4 
administration, at the time of maximal liver damage (Figure 4 A and Figure 4B). 
Moreover MIP-3α and CX3CL1 were also significantly up-regulated at the 24h and 
48h time points (Figure 5). 
 
In order to characterize which cells account for the massive leukocyte infiltration 
(Figure 4: A, C) into the injured liver at 24h and 48h, the liver sections were stained 
for the myeloid marker CD11b (expressed on monocytes/macrophages and 
neutrophils) and a properly fluorescently labelled secondary antibody. 
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Figure 5: Real Time gene expression analysis of monocyte attracting chemokines The 
monocyte attracting chemokine ligands MCP-1, MIP-3α and CX3CL1 were significantly up-regulated 
at different time points after single dosage of CCl4. Data is expressed as the mean ± SD from at least 
3 independent experiments (n = 3 animals per group)   
 
The immunohistochemistry results showed that infiltrating cells largely stained 
positive for the myeloid marker CD11b (Figure 6) at 48h time point. These findings 
corroborate the importance of the role of monocytes during liver injury. 
 
 
 
 
Figure 6: Immunofluorescence analysis of liver infiltrating monocytes. The periportal leukocyte 
infiltrates after acute liver injury mainly stains positive for the myeloid marker CD11b+ (green), counter 
staining DAPI (blue). Pictures depict 100 x magnifications from its original size. 
 
 
 
The serum levels of the major monocyte attractant MCP-1 have also been analysed 
by cytometric bead array. In accordance with the real time results from hepatic MCP-
1 gene expression (Figure 5) also a significant increase in the serum levels of MCP-
1 protein were also observed, starting at 4h and peaking at 24h time point (Figure 7). 
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Figure 7: Kinetics of monocyte chemoattractant MCP-1 in serum. Monocyte chemoattracting 
protein-1 is elevated in serum at different time points especially from 4h, 24h till 48h in acute CCl4 
mediated liver injury. Data is expressed as the mean ± SD from at least 3 independent experiments  
(n = 3 animals per group)   
 
 
3.1.3 Gr-1hi but not Gr-1low monocytes are massively recruited into the injured  
          liver 
 
Blood monocytes consist of two principle subsets (10) based on their Gr-1(Ly-6C) 
expression. In order to elucidate if different monocyte subsets also exist in the liver, 
WT mice were treated with CCl4 and sacrificed after 48h and analysed the liver 
infiltrating cells by multicolour FACS. A massive infiltration of CD11b+ F4/80+ 
monocytes into the injured liver (Figure 8: A) was observed and two different 
population of monocytes CD11b+F4/80+ and CD11b+F4/80low cells have also been 
observed. Monocytes were further characterized into two subgroups by their Gr-1 
expression and CD11c expression (Figure 8: B). Gr-1 expression and CD11c 
expression analysis shows that the major liver infiltrating CD11b+F4/80+ population 
express considerably higher amount of Gr-1 and less CD11c (Figure 8:B upper 
panel) whereas the other CD11b+F4/80low population express lower amounts of Gr-1 
and considerably higher amounts of the dendritic cell marker CD11c (Figure 8:B 
lower panel). 
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Figure 8: FACS analysis of monocyte subsets in the liver. (A) Flow cytometric analysis of 
intrahepatic leukocytes, gated on CD45+ and live cells revealed massive influx of CD11b+F4/80+ 
monocytes after 48h of CCl4 mediated liver injury. (B) Gr-1+ and CD11c expression analysis reveals 
two subsets of monocytes in the infiltrating CD11b+ cells. 
 
 
From these experiments, it was possible to identify two monocytes subsets inside 
the injured liver that mirror the blood monocyte subsets. Interestingly, the infiltration 
of the two subsets was differentially regulated following liver injury. The 
CD11b+F4/80+Gr-1+  subset massively increased after CCl4 challenge, representing 
up to 50% of the intrahepatic leukocytes 24h to 48h after damage (Figure 9:A) and 
10% to 12% of the total liver cells (Figure 9:B) 
 
                
 
Figure 9: Kinetics of infiltrating monocyte subsets during CCl4 mediated acute liver injury. 
(A) CD11b+F4/80+Gr-1+ monocyte subset massively infiltrates at 24h and 48h, which comprises (B) up 
to 12% of the total liver cells at 48h when compared to their CD11b+F4/80low cells. Data is expressed 
as the mean ± SD from at least 2 independent experiments (n = 5 animals per group).   
 
CD11b+F4/80low cells only mildly increased after CCl4 administration, and their 
relative contribution to the intrahepatic leukocytes remained constant throughout our 
kinetic study (Figure 9: A, B)  
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To determine whether these monocyte subsets actively endorse liver damage or 
rather represent an elemental reaction following the toxic injury, WT mice were 
treated with clodronate-loaded liposomes which transiently deplete circulating 
monocytes and liver resident macrophages (85). During systemic 
monocyte/macrophage depletion, 12h after liposome injection, liver injury was 
induced by CCl4 (Figure 10: A). Even though monocytes were fully depleted from the 
blood and liver (Figure 10: B, C, D), the magnitude of liver injury after CCl4 was not 
affected (Figure 10: E), indicating that the differential recruitment of monocyte 
subsets into the injured liver does not directly promote the acute hepatic damage in 
this model. 
 
3.1.4 CCR2 is critical for recruitment of Gr-1+ intrahepatic monocyte-derived 
         cells 
 
The strong infiltration of Gr-1hi monocytes after liver injury prompted us to investigate 
which chemokines might be involved in hepatic Gr-1hi monocyte subset recruitment.  
Gr-1hi monocytes express high levels of the chemokine receptor CCR2, additionally 
CCR1 and CCR6 whereas Gr-1low monocytes express high levels of CX3CR1, CCR5 
and CCR6 (9, 10). After acute CCl4 induced liver injury, intrahepatic expression of the 
ligands for CCR2, CCR6 and CX3CR1 (MCP-1, MIP3α and CX3CL1 respectively) 
were significantly up-regulated (Figure 5). Since the ligands were up-regulated, role 
of the chemokine receptors CCR2 and CCR2/6 in recruiting the monocyte subsets 
were also tested. 
 
When Ccr2 and Ccr2/Ccr6-deficient mice were challenged with CCl4, the degree of 
hepatic damage was equal to WT animals (Figure 11: A). However leukocyte 
infiltration was significantly reduced after injury (Figure 11: B). When gated for 
CD11b+F4/80+ from the total liver infiltrating CD45+ leukocytes, the reduced 
leukocyte infiltration could be attributed to a significantly lower accumulation of 
CD11b+F4/80+Gr-1+ intrahepatic monocyte-derived cells in Ccr2 and Ccr2/Ccr6-
deficient mice (Figure 12). 
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Figure 10: Monocyte Infiltration is dispensable for initiation of acute CCl4 liver injury.  
(A) Scheme of the experimental procedure in WT mice for depleting the circulating monocytes before 
induction of toxic liver injury. (B) Representative FACS plots showing the efficiency of monocyte 
depletion from the circulation after 4h and 24h of liver injury after depleting monocytes by clodronate 
loaded liposomes in contrast to PBS-loaded control liposomes. (C) Statistical analysis of blood 
monocyte counts using FACS depicts the reduction of monocyte number when compared to PBS 
controls at two different time points even after CCl4 challenge. (D) Administration of clodronate-
liposomes also largely depletes resident and infiltrating monocytes/macrophages in the liver, as 
shown by immunohistochemistry for CD11b (green) in comparison with non depleted CCl4 treated 
tissue (PBS liposomes), counter staining of nuclei by DAPI (blue). (E) Liver injury assessment based 
on ALT measurements with and without monocyte depletion by clodronate liposomes. Data are 
expressed as the mean ± SD from at least 2 independent experiments (n = 4 animals per group).   
 
 
Statistical analysis of the infiltrating monocyte populations showed that the 
CD11b+F4/80+Gr-1+ subset was massively reduced after CCl4 challenge in Ccr2 and 
Ccr2/Ccr6-deficient mice (Figure13: A), resulting in an up to 50% reduction of the 
intrahepatic leukocytes 24h to 48h after damage (Figure13: B).In contrast the 
infiltration of CD11b+F4/80low cells does not alter after CCl4 administration and their 
relative contribution to the intrahepatic leukocytes remained constant throughout our 
kinetic study (Figure 13: C). Ccr2 and Ccr2/Ccr6-deficient mice did not differ (Figure 
13: C).These data shows the involvement of the chemokine receptor CCR2 in 
recruiting the major CD11b+F4/80+Gr-1+ monocyte subset into the injured liver, 
whereas CCR2 was not needed for recruiting the other CD11b+F4/80low monocyte 
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subset. Monocyte depletion experiment and the results from Ccr2-knockout mice 
collectively revealed that the Gr-1hi monocyte infiltration into the liver is part of the 
innate immune response to the injury rather than causative agent of the liver injury. 
 
Reduced infiltration of Gr-1hi monocytes after liver injury in the Ccr2 and Ccr2/Ccr6-
deficient mice prompted us to investigate the monocyte populations in the blood. 
Interestingly, a reduced monocyte numbers could be observed in the blood 
circulation (Figure: 14) of the chemokine receptor knockout mice. This data showed 
the importance of the chemokine receptor CCR2 not only in recruiting the monocytes 
(9, 38, 86, 87, 88) but also important in the egress of immature monocytes from the bone 
marrow (77). 
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Figure 11: Role of chemokine receptors CCR2, CCR6 in acute liver injury  
(A) Comparison of serum ALT levels at different time points between WT, Ccr2-/- and Ccr2-/-Ccr6-/- 
animals after single dosage of CCl4 shows, similarity in liver injury despite lacking of chemokine 
receptors CCR2 and CCR2/6. (B) FACS analysis of liver infiltrating leukocytes revealed significantly 
reduced numbers in Ccr2-/- and Ccr2-/-Ccr6-/- deficient animals compared to their WT counterparts. 
Data is expressed as the mean ± SD from at least 3 independent experiments (n = 5 animals per 
group)   
 
 
 
 
After CCl4-induced liver injury, serum MCP-1 was strongly upreglated (Figure 7), in 
line with high hepatic MCP-1 expression after damage (Figure 5). In contrast to WT 
animals Ccr2 and Ccr2/Ccr6-deficient mice did not mobilize bone marrow monocytes 
into peripheral blood (Figure 14) after liver injury, although their MCP-1 levels were 
unaltered. Thus, CCR2 is a critical factor for intrahepatic recruitment of 
CD11b+F4/80+Gr-1+ cells by mobilizing Gr-1hi monocytes from the bone marrow.  
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Figure 12: Hepatic Gr-1+ monocyte subset recruitment is dependent on CCR2. 
Flow cytometric analysis of intrahepatic leukocytes, gated on CD45+ and live cells revealed reduced 
CD11b+F4/80+Gr-1+ cells in Ccr2-and Ccr2/Ccr6-knockout animals. Representative FACS plots shows 
liver infiltrating CD11b+F4/80+ cells after 24h of CCl4-mediated liver injury.  
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Figure 13: Statistics of liver infiltrating CD11b+F4/80+Gr-1+ cell during acute liver injury 
(A) Liver infiltrating Gr-1+ monocytes were dramatically reduced in Ccr2-and Ccr2/Ccr6-knockout 
animals when compared to their WT counterparts, this reflects a reduction (B) in total liver leukocyte 
population. Data is expressed as the mean ± SD from at least 3 independent experiments (n = 5 
animals per group).   
 
3 Results                                                      
 
 56
              
                      
 
0
5
10
15
20
* * 
** ** 
** 
** 
*p<0.05 
**p<0.005 
0 4 24 48 
time after CCl4
%
 o
f C
D
11
5+
 o
f l
iv
e 
ce
lls
 
WT 
Ccr2-/- 
Ccr2-/-Ccr6-/-
 
Figure 14: Role of CCR2 and CCR2/6 receptors on monocyte populations in the blood  
Monocyte populations increase during acute liver injury by CCl4 in WT animals but not in Ccr2 and 
Ccr2/Ccr6 knockout animals. Data are expressed as the mean ± SD from at least 3 independent 
experiments (n = 5 animals per group)   
 
 
3.1.5 Intrahepatic Gr-1+ monocyte-derived cells are also increased during liver 
         fibrogenesis, and their recruitment is CCR2-dependent 
 
Although the acute damage was apparently not directly caused by the massive 
infiltration of Gr-1hi monocytes into the injured liver, we hypothesized that Gr-1hi 
monocytes critically regulate the intrahepatic processes occurring in response to the 
acute injury. Therefore the role of infiltrating monocytes was addressed in an 
experimental model of chronic liver injury leading to liver fibrosis. Chronic 
administration of CCl4 twice weekly for 6 weeks (Figure 15) resulted in liver fibrosis 
by a significant collagen-I deposition in WT mice concomitant with a pronounced  
Gr-1hi monocyte infiltration (Figure 16: A, B). Similar to the observations after acute 
injury, two subsets of the monocyte-derived intrahepatic cells could be distinguished 
in the fibrotic liver (Figure 16: B) 
 
However only the CD11b+F4/80+Gr-1+ monocyte subset was largely increased 
during fibrogenesis (Figure: 17A, B) while the CD11b+F4/80low monocyte subset 
remained unaltered as observed  in acute CCl4 induced liver injury.  
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Figure 15: Experimental design of CCl4 mediated chronic liver injury  
In the experimental model of chronic liver injury, CCl4 was injected twice per week for 6 weeks via i.p.  
After 6 weeks, mice were sacrificed and blood as well as liver samples were analyzed further. 
 
 
In chemokine receptor Ccr2-/- and Ccr2-/-/Ccr6-/- deficient mice, chronic CCl4 
challenge resulted in a significant reduction of the intrahepatic CD11b+F4/80+Gr-1+ 
monocyte population in comparison to WT animals (Figure 17: A, B).  
 
  
       
 
 
 
Figure 16: long term administration of CCl4 resulted in liver fibrosis. 
(A) Conventional pathological examinations such as H&E (upper panel) showed massive 
inflammation around the portal regions (upper panel) and Ladewig staining (lower panel) showed 
portal bridging and collagen deposition (blue: collagen fibers) in WT animals treated with CCl4 for 6 
weeks compared to their control animals.(B) Flow cytometric analysis of liver samples showed a 
massive infiltration of CD11b+F4/80+ cells into the chronically injured liver of CCl4-treated versus 
tracer (Oil) control animals. 
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Figure 17: Statistics of liver infiltrating CD11b+F4/80+Gr-1+ cell during chronic liver injury 
(A) Liver infiltrating CD11b+F4/80+Gr-1+ monocyte populations were dramatically increased during 
chronic liver injury in WT mice which reflects an increase (B) in total liver leukocyte population.Ccr2- 
and Ccr2/Ccr6-deficient mice had significantly reduced relative and absolute hepatic monocyte 
infiltration in response to chronic liver injury. Data are expressed as the mean ± SD from at least 2 
independent experiments (n = 6 animals per group)   
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Figure 18: Reduced Gr-1+ monocyte subset recruitment during chronic liver injury is 
associated with reduced liver fibrogenesis. (A) The extent of liver fibrosis after 6 weeks of CCl4 
was assessed by immunohistochemistry for collagen-I deposition (red) Blue: DAPI nuclei counter 
stain (B) The total Hydroxyproline content of the livers after 6 weeks of CCl4 administration *p<0.05 
versus WT. (C) Western blot analysis for α-SMA protein, a well established marker for stellate cell 
activation, from the livers after 6 weeks of CCl4 administration. Protein samples from individual mice 
are shown. 
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3.1.6 Reduced infiltration of Gr-1+ monocyte-derived cells in the Ccr2 and 
         Ccr2/Ccr6-knockout animals is associated with reduced liver fibrosis  
 
Decreased accumulation of intrahepatic CD11b+F4/80+Gr-1+ cells (Figure 17) in 
Ccr2- and Ccr2/Ccr6-deficient mice was associated with a diminished development 
of fibrosis, as evidenced by a reduced collagen-I deposition by 
immunohistochemistry (Figure: 18 A), hepatic hydroxyproline content (Figure 18: B) 
and a reduced stellate cell activation (Figure 18: C) by α-SMA expression. These 
data demonstrate a critical role of CCR2 for the recruitment of Gr-1hi monocytes 
upon chronic liver injury, which appears to play a crucial function in the development 
of liver fibrosis. 
 
The intrahepatic mRNA expression levels of the major pro-fibrogenic cytokine TGF-
β1 in the fibrotic livers were analysed by real time PCR and quantified TGFβ1 protein 
levels by ELISA from the total liver extracts. Liver samples from the WT mice 
showed an increase in TGFβ1 at mRNA as well as protein levels in fibrotic mice 
(Figure: 19A, B), whereas Ccr2- and Ccr2/Ccr6-deficient mice displayed reduced 
TGFβ1 levels. It has been reported that monocytes are the major producers of the 
pro-inflammatory and pro-fibrogenic cytokine TGFβ1 (86, 87, 88). Therefore, reduced 
TGFβ1 levels in Ccr2- and Ccr2/Ccr6-deficient mice match very well with the 
reduction in the intrahepatic CD11b+F4/80+Gr-1+ monocyte population (Figure 17: A, 
B).  
 
Next to an increased expression of pro-fibrogenic cytokine TGF-β1 (Figure 19) in 
fibrotic livers, monocyte derived matrix metalloproteinases (90,91,92) such as MMP2, 
MMP9 and MMP13 were also strongly induced in the WT animals after chronic CCl4 
mediated injury (Figure 20) whereas Ccr2-/- and Ccr2-/-/Ccr6-/- deficient mice 
displayed a reduced TGFβ1, MMP2, MMP9 and MMP 13 mRNA levels.  
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Figure 19: Reduced CD11b+F4/80+Gr-1+ monocyte subset recruitment is reflected by decreased 
profibrogenic factor TGFβ1 levels in Ccr2-and Ccr2/Ccr6-knockout mice. (A) Real time gene 
expression analysis of fibrotic livers revealed reduced mRNA levels of TGFβ1 in the Ccr2 and 
Ccr2/Ccr6 knockout animals after 6 weeks of CCl4 (B) Quantification of TGFβ1 protein levels from 
fibrotic liver extracts by ELISA. Data are expressed as the mean ± SD from at least 3 independent 
experiments (n = 3 animals per group). 
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Figure 20: Reduced CD11b+F4/80+Gr-1+ monocyte subset recruitment is reflected by decreased 
intrahepatic expression of matrix metalloproteinases (MMPs) in Ccr2- and Ccr2/Ccr6-knockout 
mice. Real time gene expression analysis of the fibrotic livers revealed reduced expression levels of 
monocyte/macrophage derived MMP2, MMP9 and MMP13 in the Ccr2- and Ccr2/Ccr6- knockout 
animals compared to their WT counterparts. Data are expressed as the mean ± SD from at least 3 
independent experiments (n = 3 animals per group). 
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3.1.7 Hepatic Gr-1+ monocyte-derived cells preferentially constitute pro- 
         inflammatory iNOS-producing macrophages and interplay in T cell 
         differentiation 
 
The mechanisms by which infiltrating Gr-1hi monocytes promote hepatic fibrosis 
upon injury were further investigated. Monocytes/macrophages can principally 
differentiate into at least two distinct functionally different populations during chronic 
inflammation and fibrogenesis: “Classically” activated M1-type macrophages that 
express iNOS and favour a T helper 1 (TH1) environment and “Alternatively” 
activated M2-type macrophages that express Arginase-2 and favour a T helper 2 
(TH2) environment (89,93).There are many experimental evidences supporting the 
interplay between macrophage differentiation and the TH1/TH2 environment 
(89,93,94,95,96). 
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Figure 21: Hepatic CD11b+F4/80+Gr-1+ derived cells differentiate into classically activated state 
or alternative state and modulate liver fibrogenesis. (A) Real time gene expression for iNOS and 
arginase-2 from the fibrotic livers of WT, Ccr2- and Ccr2/Ccr6- knockout animals. (B) intracellular 
iNOS and Arginase protein levels were measured by flow cytometry and representative plots show 
iNOS (green) Arginase (blue) expression of CD11b+F4/80+ intrahepatic monocytes isolated from 
fibrotic livers in comparison to isotype control (red solid lines). (C) Relative numbers of either iNOS or 
Arginase expressing intrahepatic CD11b+F4/80+Gr-1+ cells (in percentage of all intrahepatic 
CD11b+F4/80+Gr-1+ cells). Data are expressed as mean ± SD from at least 3 independent 
experiments (n = 3 animals per group). 
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After 6 weeks of CCl4 treatment, hepatic gene expression of monocyte-derived 
Arginase-2 was considerably higher than the classical activation marker iNOS mRNA 
levels in the Ccr2- and Ccr2/Ccr6-deficient mice compared to the WT mice (Figure 
21: A) that showed up-regulation of both factors in response to CCl4-induced 
damage. 
 
On FACS-based intracellular protein expression analysis, more intraheptic 
CD11b+F4/80+ cells differentiate into iNOS producing cells than into arginase 
expressing macrophages in WT mice as compared to Ccr2/Ccr6-deficient mice 
(Figure: 21 B, C). Consistently Ccr2- and Ccr2/Ccr6-deficient mice had a lower 
expression of TH1-specific T box transcription factor (T-bet) a marker for TH1 type T 
cells and markedly reduced levels of interferon-γ (IFNγ) (Figure: 22 A, B) a cytokine 
specific and favours TH1 differentiation of T cells (95,96,97). Moreover, these mice 
displayed higher expression of GATA-3, a transcription factor and is specific for TH2 
type T cells (96, 97, 98).  
 
Also Ccr2-and Ccr2/Ccr6-deficient mice show considerably higher amounts of IL4 
expression (Figure: 22 B) at protein levels. Consistent with these data, it has recently 
been shown that alternatively activated macrophages which express arginase-2 
suppress inflammation and fibrosis (99).  
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Figure 22: TH1/TH2 alterations in liver fibrosis 
(A) Hepatic gene expression analysis for T-bet (TH1 specific T cell transcription factor) and GATA-3 
(TH2 specific T cell transcription factor) by real time PCR shows negative regulation of TH1 response 
in Ccr2- and Ccr2/Ccr6-knockout animals in liver fibrosis. (B) Interferon-γ (IFN-γ) and interleukin-4 (IL-
4) expression of intrahepatic CD4+ T cells was assessed by intracellular staining of hepatic CD4+ cells 
+gated from CD45  live cells and isolated from fibrotic livers. Data are expressed as mean ± SD from at 
least 3 independent experiments (n = 3 animals per group). 
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3.1.8 The infiltrating Gr-1+ monocyte subpopulation promotes profibrogenic 
         actions at different tages of liver fibrosiss  
 
To further elucidate the functional contribution of Gr-1hi monocytes to liver fibrosis in 
                                        
vivo, purified CD45.1+Gr-1hi monocytes were adoptively transferred into congenic 
CD45.2+ WT or CD45.2+ Ccr2/Ccr6-deficient recipient mice at different time points of 
during CCl4 induced chronic liver injury. In an experimental “early transfer” group, 
monocytes were adoptively transferred during the first three weeks of the 6-weeks-
CCl4-administration, in a “late transfer” group during the last three weeks (Figure 23). 
 
  
 
igure 23: Experimental design for adoptive monocyte transfers during fibrogenesis 
o induce liver fibrosis, CCl  is injected twice per week for 6 weeks via i.p. Monocytes for adoptive 
o WT and 
                              
 
F
T 4
transfers were isolated from the bone marrow of WT mice (CD45.1+) and then injected int
Ccr2/Ccr6-knockout animals either during the first 3 weeks or the last 3 weeks of CCl4 challenge. 
After 6 weeks, mice were sacrificed and the blood, liver samples were analyzed further. 
 
 
 
 
   
 
 of monocytes for adoptive transfer 
WT mice contained 7% to 15% monocytes identified by positive staining for 
nalysis of the MACS isolated monocytes 
Figure 24: Isolation
one marrow from B
CD115 (left representative FACS plot). Flow cytometric a
shows >95% purity (right representative FACS plot). These isolated bone marrow-derived monocytes 
were used for adoptive transfer experiments. 
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A MACS-based separation protocol for the isolation of monocytes from the bone 
marrow of the donor WT mice (CD45.1+) was established, that resulted in a purity of 
95% or greater (Figure 24). 
 
Gr-1hi monocytes were either transferred within the first (early transfer) or final (late 
terestingly, the transfer of WT Gr-1hi monocytes not only restored fibrogenesis in 
           
transfer) 3 weeks of the 6 week CCl4 treatment (Figure 23).In both conditions, Gr-1hi 
monocytes strongly enhanced the fibrosis progression (Figure 25: A, B).  
 
In
Ccr2/Ccr6-deficient mice to WT levels, but even increased HSC activation analyzed 
by α-SMA protein expression levels by Western blot (Figure: 25 B, C) and collagen-I 
deposition analysed by immunohistochemistry in both WT and in Ccr2/Ccr6 deficient 
mice after Gr-1hi monocyte transfer (Figure 25: A). 
 
 
 
 
25: Adoptive transfer of Gr-1+ monocytes promotes liver fibrogenesis during early and 
te stages of chronic liver injury. (A) Representative immunohistochemistry of liver sections for 
Figure 
la
collagen-I (red) shows enhanced fibrosis progression in mice that have received adoptively 
transferred WT monocytes, counter stain with DAPI (blue). Western blot analysis revealed enhanced 
α-SMA protein levels at (B) early (C) and late monocyte transfer in WT and Ccr2/Ccr6-deficient mice. 
Western blots were performed from the liver samples after 6 weeks of CCl4 treatment. 
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Consequently, collagen deposition was higher after early transfer than in mice that 
had received monocytes at later periods of CCl4 treatment, due to the prolonged 
HSC activation (Figure 25). Analysis of the total hydroxyproline content also revealed 
the higher levels of collagen content (Figure 26) in the mice that received the Gr-1hi 
monocytes at earlier time points during initiation of fibrogenesis. 
 
 
                                  
Figure 26: Total liver hydroxyproline quantification after monocyte transfer in experimental 
t liver fibrosis. The hydroxyproline content of the livers of WT (black bars) and Ccr2/Ccr6- knockou
terestingly it was possible to identify the adoptively transferred monocytes 
ACS analysis of the livers from animals that had received the adoptively transferred 
exert their pro-fibrogenic actions within the hepatic compartment. 
(white bars) was assessed for the different adoptive transfer experimental conditions, 6 weeks after 
CCl4 treatment. Data are expressed as the mean ± SD from at least 2 independent experiments (n = 4 
animals per group).  
 
 
In
(CD45.1+) inside the fibrotic livers of WT as well as Ccr2/Ccr6-knockout animals 
(Figure 27: A).  
 
F
monocytes showed an increase in the total infiltrating leukocytes (Figure 27: B) as 
well as of the CD11b+F4/80+ monocytes (Figure 27: C), Furthermore, it could also be 
observed that even as late as 3 to 6 weeks after adoptive transfer, about half of the 
Gr-1hi monocyte-derived cells were still CD11b+F4/80+ macrophages, whereas the 
other cells had a more differentiated CD11b-F4/80+ resident macrophage phenotype 
(Figure 28). These data collectively demonstrate that adoptively transferred Gr-1+ 
monocytes migrate into the injured liver, differentiate into F4/80+ macrophages and 
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A 
WT mice  Ccr2-/-Ccr6-/- mice 
CD45.1 CD45.1
 
 
Figure 27: Adoptively transferred Gr-1+monocytes migrate into the injured liver. 
(A) Representative Immunohistoc
tively transferre
hemistry of liver sections stained for donor CD45.1+ cells (green) 
wed that adop d cells had migrated into the injured liver Analysis was done at 6 
nalysis of the 
            
Figure 28 c macrophages 
Adoptively transfe pient livers 
optive transfer (at 6 weeks of CCl4 treatment) and found to be differentiated 
/80+ macrophages/Kupffer cells in the liver. 
sho
weeks of CCl4 administration, 3 weeks after the last adoptive transfer (B) Statistical a
FACS data gated on CD45+ total liver infiltrating leukocytes showed an increase in total leukocyte 
numbers in the monocyte recipient mice. (C) Statistical analysis of CD11b+F4/80+Gr-1+ monocytes by 
FACS, gated on CD45+ total liver infiltrating leukocytes showed an increase in CD11b+F4/80+Gr-1+ 
monocytes count in WT recipient livers. Data are expressed as mean ± SD from at least 2 
independent experiments. 
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3.1.9 Intrahepatic Gr-1+ monocytes directly activate HSCs in a TGFβ1- 
         dependent manner 
 
hiThe adoptive transfer of purified Gr-1  monocytes demonstrated the efficient pro-
brogenic potential of bone marrow derived monocyte subsets in experimental liver 
olated from CCl4 
jected mice and tested in vitro in comparison with purified Gr-1hi bone marrow 
           
fi
fibrosis in vivo. However, it was not clear if this is general feature of Gr-1hi 
blood/bone marrow derived monocytes per se or if prior differentiation in the inflamed 
liver microenvironment is required, furthermore it was necessary to ensure that this 
is a monocyte subset specific effect and to unravel the underlying molecular 
mechanisms of monocyte-mediated hepatic stellate cell activation.  
 
Intrahepatic CD11b+F4/80+Gr-1+ monocyte subset were therefore is
in
monocytes as well as B cells and CD8+ T cells as controls for their potential to 
activate HSC.  
  +Figure 29: Intrahepatic Gr-1  monocytes directly promote HSC activation through TGFβ1 
(A) MACS isolation of intrahepatic Gr-1+ monocytes, bone marrow monocytes (Fig: 23) and splenic 
cells and CD19+ B cells after 48h from the mice administered CCl  showed > 92% purity of 
d with 
CD8+ T 4
immune cell subsets for the co-culture experiment. (B) The HSC cell line GRX was co-culture
different immune cell subpopulations as indicated, in the presence or absence of anti-TGFβ1 antibody 
(anti-TGFβ1) as indicated. As a positive control, GRX cells were stimulated with recombinant TGFβ1 
(left lower corner). 
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Monocytes from either liver or bone marrow or control cells (Figure: 29 A) were co-
cultured with the murine GRX cell line that has typical characteristics of HSCs 
            
          
(Figure: 29 B), including the potential to differentiate into myofibroblasts upon 
activation (100,101). In fact, stimulation of GRX with recombinant TGFβ1-induced 
expression of α-SMA and collagen-I in GRX cells within 48h (Figure 30). 
                        
 
Figure 30: Real time analysis of in vitro stellate cell activation 
48 hours after co-culture, RNA was isolated from the HSC and the mRNA expression for α-SMA and 
n-I was quantified using real-time PCR. Results from the qPCR were expressed as fold 
e the co-culture experiments were 
nts revealed that only liver-derived Gr-1+ monocytes, but neither 
one marrow monocytes, B cells nor CD8+ T cells were able to induce α-SMA and 
Collage
induction to HSCs alone. Data are expressed as mean ± SD and th
performed in triplicate.  
 
 
o-culture experimeC
b
collagen-I expression in GRX cells (Figure: 30). Activation of HSC by the liver 
derived Gr-1+ cells could be blocked by a TGFβ1-specific antibody (Figure 30).This 
demonstrates that Gr-1hi monocytes after their recruitment into the injured liver, 
undergo activation and differentiation in the inflamed intrahepatic environment and 
excert specific pro-fibrogenic actions on HSCs mediated by TGFβ1 signalling. 
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4.1 Monocyte infiltration during acute liver injury 
 
Recent findings show that monocytes consist of two principle subsets based on their 
chemokine receptor expression and their migratory properties (8,9,10). In humans, 
classical CD14+CD16- monocytes express the chemokine receptor CCR2, as well as 
CD64 and CD62L, whereas the non-classical CD14+CD16- lack CCR2. Their 
counterparts in mice are Gr-1hi (Ly6Chi) CCR2+ and Gr-1low (Ly6Clow) CCR2- 
monocytes respectively (8, 10). The role of monocyte subsets during liver injury and 
fibrosis was unclear. This study provides evidence for a vital role of monocyte subset 
infiltration in the development of liver fibrosis. CCl4, which is a well established 
experimental hepatotoxic agent known to mimic chronic toxic injury (e.g alcoholism) 
in humans (110,111,112,113), was used for the induction of acute as well as chronic liver 
injury. Single intraperitonial (i.p) administration of CCl4 resulted in massive liver 
damage, showing a maximum liver damage after 24h and 48h. Also a massive 
necrosis and intrahepatic infiltration of leukocytes around the periportal regions could 
be observed from the conventional pathological haematoxylin eosin (HE) staining of 
the sections from the injured liver. In support of that finding, FACS analysis revealed 
a massive influx of leukocytes into the injured liver, which peaks at 24h and 48h time 
points similar to the serum aminotransferase activity levels (Figure 4).  
 
The infiltrating leukocytes were further characterized and identified as CD11b+F4/80+ 
monocytes that massively infiltrate during the acute liver injury mediated by CCl4. 
The infiltrating CD11b+cells could be further subdivided based on their expression of 
Gr-1 and CD11c (Figure 8) and were able to identify the two subsets of monocyte 
populations inside the injured liver. In this study it has been demonstrated that 
CD11b+F4/80+Gr-1+(Ly6C+) inflammatory monocytes are predominantly recruited 
after acute liver injury, whereas the non-classical CD11b+F4/80lowGr-1low subset 
population remains unaltered during different time points we assessed. 
 
This result is in well agreement with other inflammatory models. For instance in 
experimental models of skeletal muscle injury (120), atherosclerosis development (121) 
and toxoplasmosis (122), the Gr-1+(Ly6C+) monocyte subset massively infiltrates to the 
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site of injury or infection and modulates the outcome of inflammation and infection, 
whereas the Gr-1low (Ly6Clow) monocyte subset population remained unaffected. 
 
The observation of a strong monocyte subset infiltration upon acute injury prompted 
us to speculate on the function of monocytes in this model. Therefore the circulating 
monocytes were transiently depleted and liver resident monocyte/macrophages from 
the WT mice by clodronate-loaded liposomes and performed the CCl4 induced acute 
liver injury. Although monocytes were fully depleted from the blood and from the liver 
(Figure 10), interestingly there was no significant difference between the monocyte- 
depleted animals and PBS-treated control animals with respect to the liver damage 
in acute CCl4 mediated liver injury. This finding provides the clue that the recruitment 
of Gr-1 hi monocytes into the injured liver do not directly promote the acute hepatic 
damage. Although not directly harmful or beneficial to the acutely injured organ, 
monocyte subsets may therefore modulate subsequent inflammatory cascades, 
regulating chronic inflammation and fibrogenesis. 
 
This finding is in contrast to other injury models such as experimental atherosclerosis 
(121), autoimmune encephalomyelitis (123). A very likely explanation is the nature of the 
liver injury model. CCl4 is metabolized by the hepatocytes and converted into a 
directly toxic metabolite, and the injury is therefore independent of the inflammatory 
reaction of the immune system (124). At present, it is unknown if Gr-1hi monocyte 
infiltration may promote or limit liver injury in disease models, in which the 
inflammation causes the liver damage, e.g. after Concanavalin-A-mediated hepatitis. 
 
4.2 Role of CCR2 for monocyte subset infiltration in liver injury 
 
As the migration of inflammatory Gr-1hi monocytes is largely regulated by the 
chemokine receptor CCR2 in many other acute injury models like bacterial infection, 
acetaminophen-induced hepatotoxicity, Listeria monocytogenes infection (9,10,38,74, 
77,105,106), we hypothesized that CCR2 might also mediate monocyte infiltration into 
the injured liver. Chemokine receptor Ccr2-and Ccr2/Ccr6-deficient animals were 
employed to dissect the molecular mechanisms of hepatic monocyte infiltration 
further. When Ccr2 and Ccr2/Ccr6-deficient mice were challenged with CCl4, the 
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degree of liver damage was equal to WT mice, but FACS analysis of the injured liver 
revealed a significant reduction in leukocyte infiltration (Figure 11). The reduced 
leukocyte infiltration is very well attributed to a significantly reduced intrahepatic 
accumulation of CD11b+F4/80+Gr-1+ monocytes in Ccr2-and Ccr2/Ccr6-knockout 
mice (Figures 12, 13). Also, a reduced number of circulating monocytes in Ccr2 and 
Ccr2/Ccr6 deficient animals could be observed (Figure 14). These findings 
demonstrate that infiltration of Gr-1hi monocytes in to the injured liver is critically 
dependent on the chemokine receptor CCR2. 
 
Increasing experimental evidence suggests that the chemokine receptor CCR2 
regulates Gr-1hi monocyte entry into the inflamed tissue, mainly indirectly by 
promoting the egress of immature Gr-1hi monocytes from the bone marrow into the 
circulation (77,104). According to the present data this mode of CCR2-mediated actions 
also applies to toxic liver injury; because experimental liver injury resulted in a 
sequence of hepatic MCP-1 expression and elevated serum MCP-1 levels (Figure 7) 
and peripheral monocytosis in WT animals.  
 
Moreover adoptively transferred WT Gr-1hi monocytes did traffic into the injured liver 
of Ccr2/Ccr6-deficient animals (Figure 26), corroborating that CCR2 primarily 
promotes egress of Gr-1hi monocytes from the bone marrow and not immigration into 
the injured liver. Although hepatic expression of MIP-3α, the major CCR6 ligand was 
up-regulated (Figure 5), the chemokine receptor CCR6, did not procure an additional 
effect on monocyte subset migration into the liver when compared to the Ccr2-/- 
single knockout animals unlike in the inflamed skin (108,109). However, it is important to 
note that especially upon liver injury alternative pathways of monocyte subset 
recruitment can partially compensate for the function of CCR2/MCP-1. This has also 
been demonstrated in other chronic inflammatory models such as atherosclerosis 
and CCR1, CCR5 and CX3CR1 have been identified as chemokine receptors 
involved in Gr-1hi monocyte migration (8,9,10,51,72,109). In line, we also observed a 
significant up-regulation of other potential monocyte attracting chemokine ligands 
such as CCL20 (MIP-3α) and CX3CL1 (Fractalkine) at mRNA levels (Figure 5). Their 
role in liver fibrosis is currently unknown and requires further study. 
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4.3 Monocyte infiltration during chronic liver injury 
 
The infiltration of Gr-1hi monocytes during acute CCl4 mediated liver injury model 
indicated an important role for Gr-1hi monocytes during CCl4-induced chronic liver 
damage and fibrogenesis. As after acute liver injury, a massive influx of 
CD11b+F4/80+Gr-1+ monocytes could be observed, which constitutes up to 6% of the 
total liver cells, after 6 weeks of CCl4 treatment (Figure 17).  
 
As in the acute model, a reduced CD11b+F4/80+Gr-1+ monocyte infiltration could be 
observed in chemokine receptor Ccr2- and Ccr2/Ccr6- knockout animals in CCl4 
induced chronic model of liver injury (Figure 17). A very strong indicator for the 
functional relevance of Gr-1hi monocyte infiltration for fibrosis progression is the 
finding that Ccr2-deficient animals not only lack intrahepatic monocytes upon injury, 
but also show reduced liver fibrosis (Figure 18). This finding was confirmed by two 
other independent groups, who published their results at around the same time 
(125,126). 
 
Real time gene expression analysis of monocyte-derived matrix metalloproteinases 
such as MMP2, MMP9 and MMP13 (91, 92) were highly up-regulated in WT animals, 
whereas Ccr2 and Ccr2/Ccr6-deficient animals showed a reduced MMPs expression 
levels from the fibrotic livers (Figure 20). Interestingly, collagen-I 
Immunofluorescence, hydroxyproline quantification and Westernblot analysis of α 
SMA, a well known marker for activated hepatic stellate cells revealed reduced liver 
fibrosis in Ccr2 and Ccr2/Ccr6-deficient animals (Figure 18). It has been known that 
monocyte/macrophages are the major producers of the pro-fibrogenic cytokine 
TGFβ1 (86, 87, 88) under inflammatory conditions; reduced infiltration of monocytes in 
the chemokine receptor-knockout animals reflected was reflected by a reduced 
TGFβ1 at mRNA as well as protein levels in Ccr2 and Ccr2/Ccr6-deficient mice 
(Figure 19). Reduced CD11b+F4/80+Gr-1+ monocyte infiltration and reduced 
fibrogenesis suggested a direct link between monocyte subset infiltration and liver 
fibrosis. In line, selective depletion of (total) monocytes/macrophages during fibrosis 
progression in CD11b-DTR mice has been found to reduce hepatic fibrosis (5).  
 
 
4 Discussion                                                 
 
 73 
 
4.4 Monocyte/macrophage differentiation during liver fibrosis 
 
Chronic inflammation leads to an alteration in the T-helper cell derived cytokine 
responses TH1 and TH2 
(89) which influences the differentiation of infiltrating 
monocyte/macrophages into either classically activated macrophages which express 
iNOS (inducible nitric oxide synthase) or alternatively activated macrophages which 
express Arginase (94,95,96,97,98,99). These differentiated monocyte/macrophage 
populations further modulate the alterations and differentiation of T helper cells 
(100,101,102). Liver fibrosis is a chronic inflammatory condition and is modulated by 
TH1/TH2 cytokine response 
(94, 95, 96, 97, 98). In mouse models of liver fibrosis the 
TH1/TH2 cytokine response is strain-dependent. BALB/c mice are regarded as 
preferentially fibrogenic and exhibit a TH2 response during the wounding response, 
whereas C57BL/6 mice are prone to TH1 responses
 (94). In the current model, the 
reduced intrahepatic accumulation of of Gr-1hi monocyte-derived cells in Ccr2 and 
Ccr2/Ccr6-deificent mice resulted in impaired TH1 responses in the chronically 
injured liver. Impaired TH1 cytokine responses in Ccr2 knockout mice have been 
previously attributed to alterations of monocyte migration in a model of acute 
peritonitis (103). 
 
This finding indicates that the phenotype of the CD11b+F4/80+ monocyte derived 
cells after liver injury has striking similarities to monocyte-derived cells in other 
organs after injury (104, 105, 106). It shares the expression of Gr-1/Ly6C while lacking 
Ly6G or high amounts of CD11c with inflammatory monocytes that are recruited into 
the ileum and peritoneal cavity after infection with the parasite Toxoplasma gondii 
(106). It also shares the preferential differentiation into iNOS-producing cells in the 
chronic injury model of Listeria monocytogenes infection, in which inflammatory 
monocytes are recruited into the spleen (77,104,107). CD11b+F4/80+ monocyte derived 
cells from the Ccr2-deficient animals shows an alternatively activated phenotype due 
to the altered TH1/TH2 balance (Figures: 20, 21). These findings indicate that Gr-1
hi 
monocytes preferentially differentiate into “classically activated macrophages” 
(iNOS+) and that the magnitude of CD11b+F4/80+ intrahepatic cells guides the 
TH1/TH2 environment during liver fibrogenesis.  
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4.5 Monocyte subset function during liver fibrogenesis 
 
In order to prove the functional role of infiltrating monocytes during liver fibrosis 
development WT (CD45.1+) bone marrow monocytes were adoptively transferred 
into the WT and Ccr2/Ccr6-deficient mice during chronic CCl4 treatment.  Adoptively 
transferred Gr-1+ monocytes trafficked into the injured liver (Figure 26); after adoptive 
monocyte transfer, a higher level of HSC activation, collagen deposition and 
fibrogenesis was observed. Gr-1hi monocyte transfer not only enhanced liver fibrosis 
in Ccr2/Ccr6-deficient mice but also in WT animals (Figures 24, 25). The additional 
pro-fibrogenic effect of adoptively transferred monocytes suggests that the pathways 
preferentially recruiting Gr-1hi monocytes into the chronically injured liver are highly 
up-reglated and are not fully saturated by the endogenous monocyte influx. In 
support of this finding, there have been recent reports in different models of injury 
and inflammation such as skeletal muscle injury and atherosclerosis suggesting that 
the massive infiltration of Gr-1hi monocytes to the sites of muscle injury, or 
atherosclerotic plaques and supports myogenesis (120), or exacerbates 
atherosclerosis (121) respectively. 
 
4.6 Dissection of molecular mechanism underlying monocyte-  
      mediated hepatic stellate cell activation and fibrogenesis 
 
A possible molecular mechanism how monocyte/macrophages interact with hepatic 
stellate cells (HSCs) during liver fibrogenesis is the release of several pro-
inflammatory molecules including TGFβ1, PDGF or TNF-α that are important 
activators of HSC (42,78). Hepatic stellate cells (HSCs) on the other hand express 
MCP-1/CCL2 and also the chemokines CCL3, CCL4, CXCL1, CXCL2 or CXCL10 
after activation via Toll-like receptor 4 (TLR4) dependent signals, there by facilitating 
monocyte/macrophage chemotaxis during fibrogenesis (49). 
 
From the in vivo data we hypothesized that intrahepatic CD11b+F4-80+Gr-1+ derived 
cells, just like liver resident macrophages/Kupffer cells produce TGFβ1 and thereby 
directly activate HSCs. This was confirmed in vitro by co-culturing bone marrow-
derived monocytes and monocytes from the CCl4 treated livers with the HSC cell line 
GRX for 48h. CD8+ T-and CD19+ B-cells from spleen served as controls and were 
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also subjected to co-culture experiments. The GRX cell line is a well established 
model of murine derived hepatic stellate cells and shows characteristic features of 
primary HSCs derived from the livers such as producing collagen-I upon activation 
(100,101). The co-culture experiments revealed that only the inflamed liver-derived Gr-
1+ monocytes but neither naive bone marrow derived Gr-1+ monocytes, neither 
CD8+ nor CD19+ B cells could activate the hepatic stellate cells (HSCs). Activation of 
HSCs by the liver -derived Gr-1+ monocytes could be blocked by adding anti-TGFβ1 
antibody to the culture (Figures 28, 29). Both in vivo and in vitro experiments thereby 
strongly confirm that liver-infiltrating Gr-1+ monocytes during inflammatory conditions 
directly activate hepatic stellate cells via TGFβ1.  
 
4.7 Open questions and outlook 
In this study, it has been defined that the intrahepatic monocyte-derived subsets in 
an experimental murine model of liver injury and identified Gr-1hi monocytes as 
precursors of functionally important CD11b+F4/80+ intrahepatic macrophages during 
acute and chronic liver damage. It is unclear at present how these findings translate 
into the pathogenesis of liver fibrosis in human patients. 
 
However, one can speculate that these findings are likely to be of key relevance for 
human liver disease. It has been reported that the number of macrophages 
increases during chronic liver injury and fibrogenesis (1, 3, 11, 114). Mouse Gr-1hi 
monocytes are thought to resemble the human CD14++CD16- monocytes and Gr-1low 
to human CD14+CD16+ monocyte subset (8, 10). Although human CD14++CD16- share 
many characteristics with the murine Gr-1hi monocytes, including activation markers 
or CCR2 chemokine receptor expression, some discrepancies have not been 
convincingly resolved at present. For instance, Gr-1hi monocytes constitute about 
50% of murine monocytes, while CD14++CD16- cells represent about 90-95% of the 
human monocytes (8, 10). In mice, Gr1hi monocytes are often named „inflammatory 
monocytes‟ due to their preferential recruitment to sites of inflammation and their 
pro-inflammatory differentiation potential, whereas in humans the CD14+CD16+ 
subset has long been considered to constitute „inflammatory monocytes‟ because it 
is up-regulated in many inflammatory disorders and has the potential to release high 
amounts of pro-inflammatory cytokines upon stimulation in vitro (17, 67, 86, 87). 
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In patients with liver cirrhosis, both increased peripheral CD14++CD16- and 
CD14+CD16+ monocytes have been reported in the literature (116,117). Moreover, 
consistent with the current findings in murine liver injury, up-regulated intrahepatic 
and systemic levels of MCP-1/CCL2 as well as MIP-3α/CCL20 were described in 
patients with liver cirrhosis (78, 82). Further investigations are needed to translate the 
findings from the animal models into human pathogenesis. 
 
Even though CCR2 is the major receptor involved in recruiting monocytes, there has 
been considerable number of experimental evidences suggesting the role of other 
chemokine receptors such as CCR1, CCR5, CCR6 and CX3CR1 in monocyte 
recruitment under inflammatory conditions (9, 72, 73, 109, 114, 127).  
 
The function of these receptors in liver fibrogenesis is currently under intense 
investigation. A recent report on CCR1 in liver fibrosis (127) suggested that bone 
marrow derived cells could contribute liver fibrosis and from our experimental 
evidences that the Gr-1hi monocytes could very well be the effectors cells using 
CCR1 receptor as one of the other chemokine receptors in addition to CCR2 for their 
recruitment in modulating liver fibrogenesis. Even though there have been reports on 
CX3CR1 receptor in chronic hepatitis patients 
(72, 73), there is no clear functional role 
of this receptor in liver fibrosis documented. CX3CR1 is mainly expressed by the Gr-
1low monocyte subset; this chemokine receptor is certainly an interesting candidate 
for monocyte recruitment and liver fibrogenesis. 
 
Nevertheless, the results from this murine liver injury study suggest that the 
modulation of monocyte subset recruitment into the liver and subsequent 
differentiation in the inflamed hepatic environment may represent possible novel 
approaches for interventions targeting pro-inflammatory and pro-fibrogenic actions of 
Gr-1hi monocytes (or their human counterparts) in chronic liver diseases and liver 
fibrosis. There have been evidences in other experimental models of inflammation 
such as renal glomerulosclerosis and lupus nephritis that blocking the CCR2 ligand 
monocyte chemoattractant MCP-1 by an L-enantiomeric RNA aptamer otherwise 
called “Spiegelmer” could ameliorate experimental nephritis in mice (128,129,130). 
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Antagonizing MCP-1 mediated Gr-1hi monocyte infiltration could therefore be a 
realistic therapeutic approach for liver fibrosis as well. 
 
Even though blocking monocytes during liver fibrogenesis could be an interesting 
approach for the limiting the fibrosis progressions but one has to be aware that 
monocytes may also fulfill critical actions during fibrosis regression. Recent reports 
suggest an important role of monocytes/macrophages in resolving the established 
liver fibrosis. Depleting monocytes using diphtheria toxin in CD11b-DTR mice after a 
well established liver fibrosis could halt the resolution of the fibrotic scar (131,132). 
Moreover liver infiltrating monocyte/macrophages are believed to be the major 
source of the matrix metalloproteinase-13 (MMP13), which is mainly responsible for 
degradation the extracellular matrix in the fibrotic livers (133). Modulating the 
monocyte infiltration during the fibrosis regression could thus also yield a beneficial 
effect in the resolution of the fibrotic scar. Therefore it is very likely that monocytes 
are the “double-edged sword” of hepatic fibrosis. Modulating monocyte subsets 
based on the fibrotic conditions could yield a beneficial or deleterious effect, and this 
field is open for further research. 
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Monocytes are key players of the innate immune system and crucially modulate 
tissue inflammation after injury. Mammalian monocytes consist of two principle 
subsets that display different chemokine receptor expression levels. In humans, the 
classical monocyte CD14++CD16- subset expresses CCR2, CD64, CD62L and low 
levels of the fractalkine receptor CX3CR1, whereas the non-classical CD14lowCD16+  
monocyte subset expresses high levels of CX3CR1 and lack CCR2. Their 
counterparts in mice are CCR2+Gr-1hi and CCR2-Gr-1low monocytes, respectively. 
Liver fibrosis is the consequence of chronic liver inflammation, which is characterized 
by the accumulation of extracellular matrix proteins such as collagen-I. Patients with 
liver fibrosis are at high risk of developing liver cirrhosis or hepatocellular carcinoma. 
The functional contribution of monocyte subsets to chronic liver inflammation and 
liver fibrosis are as of yet not well understood. This study addresses the role of 
monocyte subsets in liver inflammation and fibrosis, using the well established model 
of carbon tetrachloride (CCl4)-induced toxic liver injury in C57Bl/6 mice.  
 
Acute CCl4-mediated liver injury resulted in the massive infiltration of Gr-1hi 
monocytes into the liver of WT animals, which peaked at 24h and 48h.  
Intrahepatic recruitment of the Gr-1hi monocyte subset was markedly reduced in 
Ccr2-/- and Ccr2-/-Ccr6-/- mice, when compared to WT animals in the model of acute 
as well as chronic liver injury. In chronic CCl4-mediated liver injury, detailed analysis 
showed that the reduced amount of CCR2+Gr-1hi monocytes in the inflamed liver 
coincides with reduced activation of hepatic stellate cells, less collagen-I 
accumulation and reduced liver fibrosis in the Ccr2-/- and Ccr2-/-Ccr6-/- mice. Adoptive 
transfer of WT monocytes into the Ccr2-/-Ccr6-/- or WT animals massively aggravates 
hepatic fibrosis.  
 
Isolated liver-derived Gr-1hi monocytes, but not control cells such as bone marrow-
derived monocytes, CD8+ T-cells or CD19+ B-cells, directly activate hepatic stellate 
cells in vitro. Inhibition of TGFβ1 in a co-culture blocked the HSC activation potential 
of liver-derived inflammatory monocytes, suggesting that liver infiltrating Gr-1hi 
monocytes activate hepatic stellate cells in a TGFβ1-dependent manner. 
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These findings provide evidences, that the chemokine receptor CCR2 is involved in 
recruiting the Gr-1hi monocytes to the inflamed liver and suggest an important role of 
these monocyte subsets for liver fibrosis progression by activating hepatic stellate 
cells via TGFβ1. Thus, modulating Gr-1hi monocyte infiltration during chronic liver 
inflammation could possibly be a novel therapeutic approach to control liver fibrosis 
in humans. 
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Monozyten sind essentielle Komponenten der angeborenen Immunabwehr und 
modulieren entscheidend die Entzündungsreaktion nach einer Gewebsschädigung. 
Monozyten von Säugetieren bestehen aus zwei unterschiedlichen Subpopulationen. 
Beide Subpopulationen weisen eine unterschiedliche Expression verschiedener 
Chemokinrezeptoren auf. Beim Menschen wird auf den sogenannten „klassischen“ 
Monozyten (CD14++CD16-) CCR2, CD62, CD62L und in geringem Maße der 
Fractalkin-Rezeptor CX3CR1 exprimiert. „Nicht-klassische“ CD14
lowCD16+ 
Monozyten hingegen zeichnen sich durch die fehlende Expression von CCR2 und 
eine erhöhte Expression von CX3CR1 aus. Die entsprechenden Subpopulationen in 
der Maus werden als CCR2+Gr-1hi und CCR2-Gr-1low bezeichnet.  
 
Leberfibrose ist die Folge chronischer Leberentzündungen. Kennzeichnend hierfür 
ist die Akkumulation extrazellulärer Matrixproteine wie Kollagen-I. Patienten mit 
Leberfibrose haben ein erhöhtes Risiko, eine Leberzirrhose oder hepatozelluläre 
Karzinome zu entwickeln. Die Funktion der unterschiedlichen Monozyten-
Subpopulationen in chronischen Leberentzündungen ist bis heute nicht ausreichend 
geklärt.In dieser Arbeit wird daher die funktionelle Rolle von Monozyten-
Subpopulationen in Leberentzündung und Leberfibrose anhand des gut etablierten 
Tiermodells einer Tetrachlorkohlenstoff (CCl4)-induzierten toxischen 
Leberschädigung in C57Bl/6 Mäusen untersucht. 
 
Die akute Leberschädigung mittels CCl4 resultierte in einer massiven Infiltration von 
Gr-1hi Monozyten in die Leber von Wildtyp (WT)-Tieren nach 24 und 48 Stunden. 
Sowohl im akuten als auch im chronischen Modell der Leberschädigung war die 
Rekrutierung von Gr-1hi Monozyten in Ccr2-/- und Ccr2-/-Ccr6-/- verglichen mit WT-
Tieren deutlich reduziert. Genauere Analysen chronisch durch CCl4 geschädigter 
Lebern zeigten, dass die erhöhte Anzahl an CCR2+Gr-1hi Monozyten mit einer 
verringerten Aktivierung hepatischer Sternzellen, verminderten Kollagen-I 
Akkumulation und reduzierter Leberfibrose in Ccr2-/- und Ccr2-/-Ccr6-/- Mäusen 
einherging. Der adoptive Transfer von WT-Monozyten in Ccr2-/-Ccr6-/- oder WT-
Mäuse verstärkte erheblich das Ausmaß der hepatischen Fibrose. 
 
 
Zusammenfassung                                   
                    
 97 
Verglichen mit Kontrollzellen, wie Knochenmarks-Monozyten, CD8+ T-Zellen oder 
CD19+ B-Zellen, konnten hepatische Sternzellen in vitro nur durch aus geschädigter 
Leber isolierte Gr-1hi Monozyten aktiviert werden. Die Inhibition von TGFβ1 in Ko-
Kultur blockierte das Potential der hepatischen Monozyten, HSCs zu aktivieren. Dies 
lässt darauf schließen, dass infiltrierende Gr-1hi Monozyten hepatische Sternzellen 
durch eine TGFβ1-vermittelte Interaktion aktivieren. 
 
Diese Ergebnisse zeigen, dass der Chemokinrezeptor CCR2 eine entscheidende 
Rolle bei der Rekrutierung von Gr-1hi Monozyten in die entzündete Leber spielt. 
Monozyten-Subpopulationen fördern das Fortschreiten der Leberfibrose durch die 
Aktivierung hepatischer Sternzellen via TGFβ1. Die Regulierung der Infiltration von 
Gr-1hi Monozyten in chronischen Leberentzündungen könnte daher einen neuartigen 
therapeutischen Ansatz zur Behandlung von Patienten mit Leberfibrose darstellen. 
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Abbreviation 
AIH Autoimmune Hepatitis 
ALD Alcoholic Liver Disease 
ALT Alanine Aminotransferase 
APC Allophycocyanin 
APS Ammonium Persulfate 
Arg Arginase 
Bl6 Black 6 
BDL Bile Duct Ligation 
Bp Base pairs 
BSA Bovine Serum Albumin 
C Cysteine 
CBB Coomassie Brilliant Blue 
CCl4 Carbon Tetrachloride 
CCR CC-motif Chemokine Receptor 
CD Cluster of Differentiation 
cDNA complementary DNA 
Ct Threshold Cycle 
Cy Cyanine 
d day 
DAPI Diamidino Phenylindole 
DC Dendritic Cell 
DEPC Diethyl Pyrocarbonate 
DNA Deoxyribonucleic Acid 
dNTP Deoxyribonucleoside Triphosphate 
DTT Dithiothreitol 
DMEM Dulbecco´s Modified Eagle Medium 
ECL Enhanced Chemiluminescence 
EDTA Ethylene Diamine Tetra-Acetic Acid 
e.g. for example (lat. exempli gratia) 
EGF Epidermal Growth Factor 
et al. and others (lat. et alii) 
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EtBr Ethidium Bromide 
FACS Fluorescence Activated Cell Sorting 
FCS Fetal Calf Serum 
Fig Figure 
Foxp3 Forkhead Box P3 
G Acceleration of Gravity 
g gram 
h hour 
HBSS Hank´s Balanced Salt Solution 
H&E Haematoxilin/Eosin 
HGF Hepatocyte Growth Factor 
HRP Horseradish Peroxidase 
HSC Hepatic Stellate Cell 
IFN Interferon 
IL Interleukin 
iNOS inducible nitric oxide synthase 
i.p. intraperitoneal 
i.v. intravenous 
KC Kupffer Cell 
kDa kilodalton 
kg kilogram 
k.o. Knockout 
LPS Lipopolysaccharide 
LSEC Liver Endothelial Sinusoidal Cell 
M molar 
mA milliampère 
MCP Macrophage Chemotactic Protein 
mg milligram 
μg microgram 
min minute 
MIP Macrophage Inflammatory Protein 
ml millilitre 
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μl microlitre 
mM millimolar 
μM micromolar 
NAD Nicotinamide Adenine Dinucleotide 
NADH Nicotinamide Adenine Dinucleotide Hydrogen 
NASH Non-alcoholic Steatohepatitis 
NF Nuclear Factor  
ng nanogram 
NIH National Institutes of Health 
NK Natural Killer 
NKT Natural Killer T 
NP40 Nonidet P40 
OD Optical Density 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
PE Phycoerythrin 
PerCP Peridinin Chlorophyll Protein 
PFA Paraformaldehyde 
pH potentia hydrogenii 
PKC Protein Kinase C 
PMA Phorbol-12-Myristate-13-Acetate 
PMSF Phenylmethanesulphonylfluoride 
RANTES Regulated upon Activation, Normal T-cell Expressed and 
Secreted 
RIPA Radio Immuno Precipitation Assay 
RNA Ribonucleic Acid 
ROS Reactive Oxygen Species 
RPMI Roswell Park Memorial Institute 
RT Reverse Transcription 
SD Standard deviation 
SDS PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SEM Standard Error of the Mean 
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 X 
SMA Smooth Muscle Actin 
STAT Signal Transducer and Activator of Transcription 
TAA Thioacetamide 
TAE Tris Acetate EDTA 
Taq Thermus aquaticus 
TARC Thymus and Activation-regulated Chemokine 
TEMED Tetramethylethylenediamine 
TGF Transforming Growth Factor 
TNF Tumor Necrosis Factor 
TNFR Tumor Necrosis Factor Receptor 
TRIS Tris(hydroxymethyl)aminomethane 
T-reg Regulatory T Cell 
TUNEL Terminal Deoxynucleotidyl Transferase dUTP Nick End 
Labelling 
U Unit 
UK Universitätsklinikum 
V Volt 
VCAM Vascular Cell Adhesion Molecule 
vs. versus 
wk week 
WT Wild type 
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